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Streptococcus suis is a significant cause of systemic and central nervous system (CNS) 
disease in pigs and is a welfare and economic issue worldwide. The control of S. suis 
disease in the United States is hindered by the lack of contemporary genotypic and 
epidemiological data. Lacking is information on the genomic differences between 
pathogenic or disease-causing strains and commensal strains. The overall goal of this 
dissertation was to investigate the distribution and population structure of S. suis and 
determine the genomic characteristics and virulence-associated factors of pathogenic 
strains to better understand the observed persistence and severity of S. suis infections in 
the United States. Serotyping and multilocus sequence type (MLST) are traditional 
methods for characterizing S. suis. U.S. isolates represented uniquely prevalent subtypes 
with several subtypes being associated with disease as determined by pathotype 
classifications. These results increased the knowledge about the serotype distribution and 
population structure of S. suis in the United States and established a link between subtype 
and pathotype to better predict pathogenicity. Genomic prediction of previously 
published virulence-associated genes (VAGs) of S. suis illustrated a high number of 
VAGs found across pathotypes indicating pathogenic and commensal strains share many 
VAGs. Statistical analysis of VAGs and pathotype classifications confirmed classical 
virulence markers of Eurasian strains are not sufficient for identifying pathogenic strains 
in the U.S. Regression analysis was used to predict the association of published VAGs of 
S. suis and pathotype. Results indicated that VAG profiling should be complemented with 
the two newly proposed VAGs. This supports previous studies that North American and 
Eurasian pathogenic strains are genetically different. The same MLST-VA genotype 
patterns were identified in multiple production companies, suggesting these patterns may 
be widespread as opposed to originating from a common source. Comparative pan-
genome analysis of S. suis isolates illustrated genomic regions (accessory genome) 
associated with virulence-related functions. Further analysis of the accessory genome by 
pathotype revealed three novel candidate VAGs of S. suis with potential virulence-related 
functions that may better serve as predictive markers of pathogenicity. Based on in silico 
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analysis, high resistance to tetracyclines and erythromycin were observed regardless of 
pathotype, and mobile genetic elements appeared to play a limited role in the transfer of 
antimicrobial resistance genes in S. suis. In summary, this dissertation investigated the 
genomic diversity of S. suis, the subtyping of pathogenic and commensal strains, and the 
identification and potential epidemiological surveillance of clones within and between 
swine production companies. The information provided by our work can be applied to 
diagnostics, epidemiological monitoring, and control of S. suis. 
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1.1 General Introduction 
Streptococcus suis is a bacterial pathogen which primarily occurs in nursery and 
recently weaned pigs. Systemic disease is characterized by meningitis, arthritis, 
endocarditis, pneumonia, and septicemia causing great economic losses and welfare 
concerns to the swine industry worldwide (Gottschalk and Segura, 2019). S. suis is also 
an important human pathogen and disease is characterized by meningitis, septicemia, and 
outbreaks of streptococcal toxic shock syndrome (Lun et al., 2007). Most pigs are 
colonized early in age by S. suis and serve as carriers of S. suis which can then be 
transmitted between animals or to humans (Torremorell et al., 1998). However, only 
certain strains are pathogenic or capable of causing disease, thus the identification and 
characterization of S. suis contributes to our understanding of strains associated with 
disease. 
 Characterization of S. suis by serotyping and multilocus sequence typing (MLST) 
revealed that serotype 2 (SS2) and sequence type (ST1) are the predominant subtypes 
involved in swine clinical cases, globally, but differences in distributions and prevalence 
of particular subtypes depend on the geographical location (Goyette-Desjardins et al., 
2014). A majority of the reported data on serotype and ST distributions in North America 
is from Canada with only a handful of studies reporting on isolates from the United States 
(Goyette-Desjardins et al., 2014). Therefore, an update on the characterization and 
genetic diversity of U.S. isolates is needed. Chapter 2 of this dissertation focuses on the 
serotype and MLST characterization of 208 S. suis isolates from the United States and 
utilization of a pathotype classification system to determine prevalent pathogenic 
subtypes. 
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 Many virulence-associated factors (factors and markers) have been proposed for 
S. suis and were predominantly identified in studies using SS2 strains (Fittipaldi et al., 
2012; Segura et al., 2017). Well-studied virulence-associated factors include the capsular 
polysaccharide (CPS) and extracellular protein factor (EF), muramidase-released protein 
(MRP), and suilysin (SLY) which are markers for highly virulent Eurasian SS2 strains. 
North American SS2 strains are genetically different (lack one or more of these markers) 
and less virulent than Eurasian strains (Fittipaldi et al., 2011; Auger et al., 2016a). 
However, the distribution of these markers and other virulence-associated factors in 
North America, particularly the United States, and the correlation to pathogenicity remain 
poorly known (Fittipaldi et al., 2009, 2011). Chapter 3 focuses on the genomic 
characterization of S. suis in order to determine published virulence-associated genes 
associated with systemic and central nervous system (CNS) disease. The genetic 
relatedness of U.S. isolates was also investigated to identify associations between 
virulence-associated genotypes and subtypes, for epidemiological purposes, and for 
guiding vaccine strain selection. 
 S. suis virulence-associated factors that are important for pathogenicity are poorly 
understood, especially for non-SS2 strains, may not be consistently involved in virulence, 
and/or are geographically specific (Fittipaldi et al., 2012; Segura et al., 2017). Thus, 
novel candidate virulence-associated factors should be investigated using a diverse set of 
isolates (e.g., multiple serotypes, STs). Chapter 4 of this dissertation focuses on the 
comparative genomic analysis of S. suis to determine novel candidate virulence-
associated genes, antimicrobial resistance genotypes, and other genomic characteristics of 
pathogenic isolates of different serotypes and STs. 
1.2 Literature Review 
1.2.1 Streptococcus genus 
Streptococcus taxonomy 
Streptococcus is a genus of gram-positive, encapsulated, spherical (cocci) 
bacteria. Currently, the Streptococcus genus is composed of over 65 species classified 
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into six to eight main “species groups”, the anginosus, bovis, downei, mitis, mutans, 
pyogenic, salivarius, and sanguinis groups, and several ungrouped Streptococcus species, 
including S. suis (Facklam, 2002; Richards et al., 2014). Initial classification and 
differentiation of Streptococcus species were based on morphological, cultural, 
biochemical, and serological properties (Facklam, 2002; Gobbetti and Calasso, 2014). 
Early phylogenetic studies on prokaryotic taxonomy utilized DNA-DNA hybridization 
and 16S rRNA sequencing to establish and differentiate bacterial species, and strains 
demonstrating at least 70% DNA-DNA relatedness and 97-99% 16S rRNA identity are 
generally considered members of the same species (Stackebrandt and Goebel, 1994). The 
taxonomy of the Streptococcus genus continues to be revised as molecular techniques 
evolve. 
There are a total of 35 known serotypes (SS) of S. suis (1-34 and 1/2). 16S rRNA 
analysis of S. suis serotypes 1-34 and 1/2 demonstrated a divergence between serotypes 
20, 22, 26, 32, 33, and 34 and the other 29 serotypes (Chatellier et al., 1998). Inclusion of 
other Streptococcus species further illustrated that SS32, SS33, and SS34 were more 
related to other members of the genus than to the other S. suis serotypes (Chatellier et al., 
1998). However, the biochemical profiles of all 35 serotypes were similar. SS32 and 
SS34 were later reclassified as Streptococcus orisratti based on 16s rRNA and 
chaperonin-60 (cpn60) genetic analyses (Hill et al., 2005). SS20, SS22, and SS26 were 
reclassified as Streptococcus parasuis based on DNA-DNA relatedness, sodA and recN 
phylogenies, and whole-genome sequencing (Tien et al., 2013; Nomoto et al., 2015). 
SS33 was also removed from the S. suis taxon based on molecular and biochemical 
analyses and proposed as Streptococcus ruminantium (Tohya et al., 2017).  
Evolution of the Streptococcus genus 
Whole-genome sequencing of streptococcal species has revealed important 
aspects of the evolution of this genus. Streptococcus genomes are relatively small (~2 
Mb) compared to other bacteria, have a low GC content (average 39%), and are 
comprised of an average of 2,000 protein coding genes (Lefébure and Stanhope, 2007; 
Gao et al., 2014). Further, the different Streptococcus species share a small percentage of 
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predicted genes, which varied depending on the number of genomes compared. Analysis 
of 138 Streptococcus genomes representing 42 species and all species groups indicated 
only about 9% of the predicted gene content is shared across species and comprises the 
Streptococcus core genome (Gao et al., 2014). This high species- and strain-specific 
diversity is not surprising because the genus Streptococcus is composed of both 
pathogenic and commensal bacteria found in a wide range of hosts and niche 
environments (Ruoff et al., 2003; Anisimova et al., 2007). 
Evolutionary mechanisms in bacteria include positive (adaptive) selection, a 
process in which advantageous mutations increase in frequency within a population over 
time. Genomic analysis of 26 Streptococcus genomes representing six different species 
(S. agalactiae, S. mutans, S. pneumoniae, S. pyogenes, S. suis, and S. thermophilus) 
demonstrated that up to 40% of core genes are under positive selection and selection 
pressure was greater between species than within a species (Lefébure and Stanhope, 
2007). This pattern suggests positive selection plays a larger role in species 
differentiation than strain differentiation. Functional analyses of genes under positive 
selection in bacterial pathogens revealed an enrichment of genes encoding cell 
surface/membrane and metabolic proteins (Chen et al., 2006; Petersen et al., 2007; Cao et 
al., 2017). These proteins included putative virulence factors associated with bacterial 
evasion of host immune responses, supporting the role of selection pressure in the 
evolution of pathogen-host interactions. S. suis appears to be under strong selection 
pressure which may be related to host-adaptation and its ability to infect both pigs and 
humans (Lefébure and Stanhope, 2007). 
Recombination is a major driver of strain evolution in streptococcal pathogens, 
such as S. pneumoniae, and the rate at which recombination occurs varies within the 
genus (Lefébure and Stanhope, 2007; Andam and Hanage, 2015). Horizontal (or lateral) 
gene transfer introduces novel genes, typically accessory genes not conserved across all 
members of a species, into a host genome via recombination (homologous or site-
specific) (Lawrence and Retchless, 2009; Blakely, 2015). The lateral movement of genes 
can occur within a species or between species, both closely and distantly related, enabling 
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the evolution of genetic traits that allow bacteria to adapt to new niche environments 
(Blakely, 2015). Furthermore, newly acquired genes may confer traits necessary for a 
pathogenic lifestyle, such as virulence factors and antimicrobial resistance determinants 
acquired through mobile genetic elements (Jackson et al., 2011). 
1.2.2 Streptococcus suis disease 
Clinical signs & epidemiology 
S. suis infections mostly occur in nursery and recently weaned pigs between 5 and 
10 weeks of age and clinical signs include fever, lameness, swollen joints, neurological 
signs, and sudden death (Reams et al., 1994; Gottschalk and Segura, 2019). Clinical signs 
of central nervous system (CNS) disease or meningitis are head tilt, ataxia, paddling, and 
convulsing. Clinical signs of respiratory disease, such as coughing and "thumping", have 
been observed in S. suis infected pigs (Reams et al., 1994), however, it is unclear whether 
S. suis is a primary cause of respiratory disease because S. suis is part of the porcine 
respiratory disease complex along with other respiratory pathogens (Obradovic et al., 
2021). Pigs can become infected through vertical transmission of S. suis from infected 
sow to piglets during farrowing (Amass et al., 1997) or horizontal transmission due to 
direct contact (nose-to-nose) with infected or carrier pigs (Dekker et al., 2013) with the 
latter being the predominant route. Risk factors associated with S. suis disease include 
temperature variations (Zou et al., 2018), high pig density (Hughes et al., 2009), and poor 
air quality (Bonifait et al., 2014). The potential aerosolization of S. suis and airborne 
transmission in pigs has been demonstrated for SS2 and SS1/2 (Berthelot-Hérault et al., 
2001; Bonifait et al., 2014).  
Zoonosis 
S. suis is a zoonotic pathogen and causes meningitis and septicemia in humans 
(Lun et al., 2007). Two outbreaks of human infection in China were characterized by a 
streptococcal toxic shock-like syndrome with high mortality (Tang et al., 2006) which 
had only been previously associated with S. pyogenes (group A streptococcus) infection. 
The first human infection was reported in 1968, and over 1600 reported human cases 
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have occurred, mainly in Asian countries like China, Vietnam, and Thailand (Goyette-
Desjardins et al., 2014; Huong et al., 2014). Infections in Asia are mainly associated with 
the consumption of raw pork products but also occur through occupational or household 
exposure to pigs or contaminated pork (Hughes et al., 2009; Huong et al., 2014). Human 
infections in Western countries are primarily associated with occupational hazard 
(abattoir workers, butchers, and pig breeders) and are rare due to differences in food 
consumption practices between Western and Asian countries (Arends and Zanen, 1988; 
Gottschalk et al., 2010). 
Pathogenesis 
Multiple routes of natural transmission of S. suis have been proposed with the 
oro-nasal route widely accepted as the primary route of infection in pigs (Dekker et al., 
2013). Commensal strains naturally colonize the upper respiratory tract (tonsils and nasal 
cavities), genital, and intestinal tract of pigs without causing clinical disease (Arends et 
al., 1984; Gottschalk and Segura, 2019). However, S. suis is an opportunistic pathogen 
and can cause disease under favorable conditions, such as mixed infections with viral 
(Porcine Reproductive and Respiratory Syndrome Virus, Swine Influenza Virus) or other 
bacterial pathogens (Pasteurella multocida, Mycoplasma hyopneumoniae) (Vötsch et al., 
2018; Obradovic et al., 2021). Virulent strains cause disease by colonizing the respiratory 
tract, penetrating host mucosal barriers, spreading through the bloodstream, and invading 
different organs. 
Physical barriers against S. suis colonization include a mucus layer covering the 
upper respiratory tract and the epithelial cell layer which capture and clear bacterial cells. 
Previous studies on the human pathogen Streptococcus pneumoniae suggest that the 
capsule reduces entrapment of cells in this mucus layer and its immune cell components, 
enhancing colonization and survival in the respiratory tract (Nelson et al., 2007). S. suis is 
a well-encapsulated bacterium and there is evidence that a similar mechanism for limiting 
mucus-mediated clearance is present in S. suis (Seitz et al., 2014). Adhesion of bacterial 
cells to host cells typically requires receptor-ligand interactions or the binding of bacterial 
surface components (adhesions) by host receptors (Di Martino, 2018). The S. pneumoniae 
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capsule partially hinders adherence of pneumococci to epithelial cells by reducing 
exposure of bacterial adhesin molecules embedded within the cell wall (Hammerschmidt 
et al., 2005; Novick et al., 2017). A similar pattern of reduced adherence by encapsulated 
strains was observed in S. suis (Lalonde et al., 2000; Esgleas et al., 2005). Furthermore, 
there appear to be changes in capsule thickness during different stages of infection with 
S. suis possessing a thinner capsule during colonization (Gottschalk and Segura, 2000). 
These findings suggest dynamic regulation of capsule expression during the infectious 
process.  
Characterized SS2 S. suis virulence-associated factors that contribute to adherence 
of epithelial cells include factor-H binding proteins (Fhb and Fhbp) (Roy et al., 2016), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Brassard et al., 2004; Wang and 
Lu, 2007), and suilysin (Seitz et al., 2013; Meng et al., 2016). Previous studies indicate a 
low capacity for invading host epithelial cells by encapsulated S. suis strains (Lalonde et 
al., 2000; Benga et al., 2004) but the mechanisms of invasion are not well-understood 
(Segura et al., 2016). A proposed mechanism is suilysin-mediated invasion which 
suggests the suilysin toxin binds to the host epithelial cell membrane, activates the actin 
cytoskeleton, and promotes membrane ruffling and bacterial uptake (Seitz et al., 2013). 
Alternatively, damage of cells by suilysin-induced cytotoxicity contributed to invasion of 
porcine epithelial cells (Meng et al., 2016) and human brain microvascular endothelial 
cells (BMECs) (Charland et al., 2000). 
The innate immune system plays a role in preventing the colonization and 
dissemination of bacterial pathogens. The mucosal epithelial barrier is also composed of 
antimicrobial molecules, such as lysozymes, cytokines, and chemokines secreted by 
epithelial cells and/or innate immune cells (McGuckin et al., 2015). Lysozyme resistance 
may contribute to successful mucosal colonization and is multifactorial and highly 
variable among SS1, SS2, SS7, and SS9 with SS7 and SS9 demonstrating the highest 
lysozyme resistance (Wichgers Schreur et al., 2012). S. suis has developed mechanisms 
for escaping inflammatory immune cells (e.g. neutrophils and dendritic cells), such as 
expressing the virulence-associated factors subtilisin-like protease (SspA) (Bonifait and 
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Grenier, 2011) and serine protease (Vanier et al., 2009) that degrade or cleave 
chemokines reducing the recruitment and/or activation of the immune response. 
Additionally, S. suis SS2 may promote an exacerbated release of inflammatory mediators 
by monocytes and macrophages, contributing to the development of sepsis and meningitis 
(Segura et al., 1999; Dominguez-Punaro et al., 2007). The role of the host complement 
system in protecting against invasive S. suis infection is debatable as the efficiency of 
complement in clearing S. suis varies depending on the animal model (Segura et al., 
2016). Virulence-associated factors of S. suis can interfere with complement by inhibiting 
deposition of complement proteins (opsonization), inactivating the alternative 
complement pathways, and/or degrading complement molecules, which prevents 
subsequent complement-dependent killing (e.g. phagocytosis) (Fittipaldi et al., 2012; 
Segura et al., 2016). These factors include Fhb, CPS, suilysin, DltA, and PdgA 
(peptidoglycan N-deacetylation). Suilysin also protects S. suis against the immune 
response via its cytotoxic effects against monocytes and neutrophils (Segura and 
Gottschalk, 2002; Chabot-Roy et al., 2006). Various other virulence factors, such as 
proteins associated with nutrient uptake (AdcR, Zur, FeoB, TroA), have been identified 
in vitro and/or in vivo as contributing to survival in blood and dissemination to different 
organs (e.g. liver, lung, heart) (Fittipaldi et al., 2012; Arenas et al., 2019). 
In the natural route of infection, S. suis first becomes systemic and can then 
develop into CNS disease. Although the mechanism for the development of meningitis in 
pigs in not fully understood, the hypothesis states meningeal pathogens must transverse 
the blood-brain barrier (BBB) and/or the blood-cerebrospinal fluid (CSF) barrier to cause 
meningitis (Kim, 2008; Gerber and Nau, 2010). S. suis SS2 strains have been shown to 
adhere to but not invade human umbilical vein endothelial cells (Charland et al., 2000), 
while being shown to adhere to, invade, and survive within porcine BMECs (Vanier et 
al., 2004). Multiple virulence-associated factors are involved in the interactions between 
S. suis and BBB cell types of human and porcine origin (Gottschalk and Segura, 2000; 
Fittipaldi et al., 2012). Fhb binds to Gb3 expressed on the surface of BMECs (Kong et 
al., 2017) while enolase binds to the extracellular matrix proteins fibronectin and 
plasminogen (Esgleas et al., 2008) both promoting adhesion to BMECs (human and 
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porcine, respectively) and paracellular translocation (BBB permeability) of S. suis. 
Enolase can significantly increase BBB permeability by inducing leukocyte migration via 
IL-8 secretion and/or porcine BMEC apoptosis (Sun et al., 2016; Liu et al., 2021). This 
increased recruitment of leukocytes into the CNS plays a role in the development of 
meningitis. The "Trojan horse" or "modified Trojan horse" theory has been proposed as a 
mechanism for S. suis to cross the BBB (Williams and Blakemore, 1990; Gottschalk and 
Segura, 2000). This hypothesis suggests that S. suis travels to the BBB while inside or 
surface-associated with monocytes which transverse into the subarachnoid space. 
The blood-CSF barrier, formed by choroid plexus epithelial cells (CPEC) and 
tight junctions, is another potential site for bacterial entry into the CNS (Engelhardt and 
Sorokin, 2009). Multiple studies have reported lesions at the choroid plexus of infected 
animals (pigs and mice) (Madsen et al., 2002; Dominguez-Punaro et al., 2007), however, 
investigation of invasion and translocation across this barrier were limited due to the lack 
of appropriate in vitro models. Tenenbaum et al. (2009) utilized a functional in vitro 
porcine CPEC model, as determined by intact tight junction function and transepithelial 
electrical resistance values, and demonstrated that S. suis invade CPECs in a polar 
fashion from the basolateral side (Tenenbaum et al., 2009). Similar observations were 
made using a human model of the blood-CSF barrier (Schwerk et al., 2012). As with 
migration across the BBB, S. suis can disrupt barrier function through apoptosis or 
necrosis of porcine CPECs (Tenenbaum et al., 2005, 2006). 
The gastrointestinal tract has been proposed as a secondary site of infection in 
piglets and a common route of infection in humans (Gottschalk and Segura, 2019). 
Quantification of S. suis within the gastrointestinal microbiota suggests S. suis colonizes 
the intestine after weaning (21 days of age) (Su et al., 2008). SS2 human and SS9 porcine 
clinical strains illustrated significantly higher adhesion to human intestinal epithelial cells 
(IEC) and porcine IECs, respectively (Ferrando et al., 2015). In addition, translocation 
across human EICs was associated with CC1. These results agree with previous studies 
reporting the zoonotic potential of SS2 but not SS9 (Goyette-Desjardins et al., 2014). SS2 
is capable of translocating across the porcine gastrointestinal tract in vivo after oral 
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(Ferrando et al., 2015) or intestinal (Swildens et al., 2004) challenge, infecting multiple 
organs, and causing disease. The low survival rate of SS2 and SS9 strains in the porcine 
stomach may indicate the porcine stomach is an effective barrier against oro-
gastrointestinal infections but further studies are needed (Warneboldt et al., 2016). 
Treatment and prevention 
Beta-lactam antibiotics such as penicillin, ampicillin, ceftriaxone, and ceftiofur, 
and fluoroquinolone antibiotics such as enrofloxacin are used to treat S. suis infections 
(Seitz et al., 2016). Globally, resistance to penicillin and other beta-lactam antibiotics is 
generally low among S. suis isolates, while resistance to tetracyclines has been reported 
in both clinically healthy and diseased pigs in the Americas, Asia, and European 
countries (Seitz et al., 2016; Hernandez-Garcia et al., 2017; Arndt et al., 2019; Hayer et 
al., 2020; Tan et al., 2021). Regional and geographical differences in antimicrobial 
resistance patterns of S. suis have been observed, suggesting the importance of 
monitoring antimicrobial resistance patterns in different regions (Seitz et al., 2016; 
Yongkiettrakul et al., 2019; Hadjirin et al., 2020). The movement towards prudent and 
responsible use of antimicrobials in pigs and humans may improve both animal and 
human health by preventing or reducing antimicrobial-resistant bacteria. 
An effective cross-protective vaccine for S. suis is strongly needed but difficult to 
attain partially due to the wide genetic and phenotypic variability of S. suis, and vaccine 
efficacy is largely limited to protection against homologous challenge. Homologous 
protection against S. suis challenge has been investigated for serotypes 1, 2, 1/2, 3, 9, and 
14, and few vaccine strains have been investigated in field trials (Segura, 2015). Whole-
cell bacterin vaccines provide varying levels of protection against homologous challenge 
with most providing low or no protection against morbidity and/or mortality (Segura, 
2015). One approach for eliciting a stronger immune response against bacterial cells is to 
expose cell wall proteins of the vaccine strain. Previous studies demonstrated a survival 
rate of 100% and a reduction in clinical signs in pigs vaccinated with nonencapsulated 
mutant strains (whether live or killed) (Wisselink et al., 2002; Fittipaldi et al., 2007), 
which was comparable to full protection induced by a formalin-killed virulent capsulated 
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strain (Wisselink et al., 2002). There is also evidence that live attenuated or avirulent 
strains (SS2) can confer good protection in mice (Quessy et al., 1994; Li et al., 2019) and 
pigs (Holt et al., 1988; Busque et al., 1997; Fittipaldi et al., 2007) against homologous 
challenge, although multiple immunizations were given. Only two studies, to our 
knowledge, have reported on the efficacy of SS9 bacterin vaccines. Dekker et al. (2012) 
utilized a pig model optimized for evaluating transmission and colonization (not 
mortality or clinical signs), and demonstrated that vaccination against a homologous SS9 
strain did not reduce transmission nor colonization (Dekker et al., 2012). Buttner et al. 
(2012) reported that a SS9 bacterin vaccine elicited significant protection against 
mortality in pigs against heterologous SS9 challenge (Büttner et al., 2012). Adjuvant 
formulation can influence the immunogenicity and protective efficacy of a S. suis 
vaccine. Formulation of vaccines with water-in-oil emulsion adjuvants reduced both 
mortality and clinical signs in pigs (Holt et al., 1990; Wisselink et al., 2001; Pallarés et 
al., 2004) while an aluminum hydroxide-based adjuvant failed to induce good protection 
(Holt et al., 1990; Wisselink et al., 2001). Maternal immunity in piglets from sows 
immunized with autogenous vaccines is inconsistent due to highly variable vaccine 
strains (different serotypes), vaccination protocols, and types of challenge (homologous 
vs heterologous) (Segura, 2015; Corsaut et al., 2020, 2021). 
Immune response to heterologous challenge is variable between and within 
serotypes. Immunization of pigs with a formalin-killed bacterin protected against 
heterologous SS2 challenge, although cross-protection could be attributed to a common 
MRP+/EF+ phenotype (Wisselink et al., 2001). A SS2 (MRP+EF+SLY+) bacterin 
vaccine failed to induce significant opsonizing antibodies or to protect against a virulent 
SS9 (MRP*+/SLY+) strain (Baums et al., 2009). Jiang et al. (2019), however, described 
the cross-protective potential (66% protection) of a SS2 subunit vaccine against SS9 
infection (Jiang et al., 2019). Vaccines containing SS1/2 protected well against challenge 
with SS1 and SS2, but immunization with SS1 did not protect against SS2 and vice versa 
(Kebede et al., 1990; Foster et al., 1994). Inconsistent results have been published on the 
efficacy of SS2 vaccines against heterologous challenge with different STs of SS2 
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(Quessy et al., 1994; Aranda et al., 2009), providing further proof that protection may be 
strain specific and a diverse set of serotypes and STs needs to be evaluated. 
Among the many putative and proposed virulence-associated factors of S. suis, 
only a few, mostly surface-associated proteins, have been evaluated for their 
immunogenic properties and capacity to induce cross-protection (Segura, 2015). The CPS 
is poorly immunogenic (Calzas et al., 2017; Goyette-Desjardins et al., 2020) but 
administering SS2 CPS with specific adjuvants and/or preparing a glycoconjugate 
improved levels of opsonizing SS2-specific anti-CPS antibodies (Elliott et al., 1980; 
Goyette-Desjardins et al., 2016) and provided significant protection of pigs against 
systemic infection (Goyette-Desjardins et al., 2016). Furthermore, characterization of 
monoclonal antibodies indicated that the glycoconjugate vaccine elicited a serotype-
specific protective response (Goyette-Desjardins et al., 2019). Antigens conserved across 
many different S. suis serotypes may serve as cross-protective candidates for a 
"universal" vaccine. Conserved virulence factors of S. suis demonstrating good 
immunogenicity include MRP (Baums et al., 2009; Li et al., 2017), Sao (Li et al., 2006), 
enolase (Feng et al., 2009; Zhang et al., 2009; Dumesnil et al., 2019), and suilysin 
(Jacobs et al., 1994; Liu et al., 2009, p. 201). An MRP and EF subunit vaccine induced 
good protection against homologous and heterologous S. suis challenges in a pig model 
and significantly greater than MRP and EF alone, but protection was adjuvant-specific 
(Wisselink et al., 2001). Similar adjuvant-specific protection was observed for Sao (SS2 
infection) (Li et al., 2006, 2007) and enolase (SS2 or 7 infection) (Feng et al., 2009, p. 
200; Zhang et al., 2009, p. 200), but contradictory results on the effects of adjuvant 
formulation have also been reported (Esgleas et al., 2009; Dumesnil et al., 2019). Despite 
the promising results in experimental trials, development of cross-protective subunit 
vaccines is still a challenge because virulent strains may lack several virulence-associated 
factors (Gottschalk and Segura, 2000; Segura et al., 2017).  
1.2.3 Molecular techniques for the characterization and subtyping of S. suis 
Serotyping 
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There are a total of 35 known serotypes of S. suis (1-34, and 1/2), however six 
have been reclassified as Streptococcus orisratti (SS32 & SS34), Streptococcus parasuis 
(SS20, SS22, and SS26) or Streptococcus ruminantium (SS33) (Hill et al., 2005; Tien et 
al., 2013; Tohya et al., 2017). Traditionally, serotype is determined by agglutination of 
the S. suis capsule to reference antisera, thus failing to serotype non-encapsulated strains 
(non-typeable). Multiplex PCR assays were developed to detect serotype-specific 
capsular polysaccharide synthesis (cps) genes of S. suis and determine serotype using two 
to four sets of multiple PCR amplifications (Liu et al., 2013; Kerdsin et al., 2014; Okura 
et al., 2014). These multiplex PCR assays were able to correctly determine the serotypes 
of human and porcine field isolates and of isolates non-typeable by serological assays but 
are not able to distinguish between SS2 and SS1/2 and SS1 and SS14. Sequence analysis 
of non-typable porcine strains led to the discovery of 27 novel cps loci (NCLs) and the 
development of molecular assays for identifying these NCLs (Pan et al., 2015; Zheng et 
al., 2015, 2017; Qiu et al., 2016; Huang et al., 2019). Whole-genome sequencing and in 
silico serotype determination eliminates the need for multiple serological or PCR assays, 
can characterize hundreds of isolates in a single assay, and differentiates between SS2 
and SS1/2 and SS1 and SS14 (Athey et al., 2016). 
Serotype distributions of S. suis vary by geographical location and provide 
valuable information on the prevalent subtypes affecting swine herds (Goyette-Desjardins 
et al., 2014). Globally, SS2 (and often including SS1/2 in the case of multiplex PCR) is 
the predominant serotype isolated from diseased pigs according to published studies from 
North America (Goyette-Desjardins et al., 2014; Gottschalk and Lacouture, 2015), Asia 
(China) (Goyette-Desjardins et al., 2014; Zhang et al., 2019), South America (Brazil, 
Argentina) (Goyette-Desjardins et al., 2014; Matajira et al., 2019), some European 
countries (Denmark, France, Germany, Italy, United Kingdom) (Goyette-Desjardins et 
al., 2014; Prüfer et al., 2019), and Australia (O’Dea et al., 2018). However, the data from 
Denmark, France, Italy, and the U.K. were collected prior to 2000 and may not represent 
current distributions in these European countries. In the Netherlands and Spain, SS9 is 
frequently recovered from diseased pigs, followed by SS2 and SS7 (Goyette-Desjardins 
et al., 2014; Willemse et al., 2016), however, an update on the distribution of serotypes in 
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European countries is needed to verify this shift from SS2 to SS9. The virulence of 
predominant serotypes was confirmed in experimental infection models in which SS1 
(Smith et al., 1996; de Greeff et al., 2011), SS2 (Vecht et al., 1992; Beineke et al., 2008), 
SS7 (Boetner et al., 1987; Rieckmann et al., 2018), or SS9 (Beineke et al., 2008; 
Willemse et al., 2019) induced specific S. suis clinical signs and mortality with notable 
differences in virulence between and within serotypes. 
A majority of reported human cases of S. suis infection are caused by SS2. The 
serotype distributions of human isolates in Asia and Europe, where the most cases were 
reported, have been heavily investigated but data from countries with sporadic cases of 
human infections is limited or unverified (Goyette-Desjardins et al., 2014). Overall, only 
serotypes 1, 2, 4, 5, 9, 14, 16, 21, 24 and 31 are currently known to cause disease in 
humans (Goyette-Desjardins et al., 2014; Hatrongjit et al., 2015; Kerdsin et al., 2017). 
Serotyping of isolates recovered from healthy pigs is of increasing importance as it 
provides information on the population structure of S. suis in carrier animals (Marois et 
al., 2007; Luque et al., 2010; Hoa et al., 2011; Thongkamkoon et al., 2017; Zou et al., 
2018; Denich et al., 2020; Zhang et al., 2020). This is of high relevance to zoonotic 
transmission because carrier pigs are a major reservoir of serotypes capable of causing 
human infection (Hoa et al., 2011; Thongkamkoon et al., 2017; Zou et al., 2018). 
Serotypes 2, 9/32 (cross-reacted), and 21 were frequently isolated from tonsil samples of 
slaughterhouse pigs in southern Vietnam (Hoa et al., 2011). Similarly, Thongkamkoon et 
al. (2017) identified 8 of the 10 serotypes associated with human disease in tonsil 
samples of clinically healthy pigs (Thongkamkoon et al., 2017). 
MLST 
Multilocus sequence typing (MLST) is a nucleotide sequence-based technique for 
subtyping bacteria. The traditional MLST method for subtyping S. suis relies on the PCR 
amplification and sequencing of seven housekeeping genes (aroA, cpn60, dpr, mutS, 
recA, and thrA) (King et al., 2002). The use of a common MLST scheme affords high 
discrimination, reproducibility, and increased accessibility of data over the Internet. 
Currently there are 1654 registered sequence type (ST) profiles (as of August 2021) of S. 
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suis (pubmlst.org), however, only a small number of STs have been shown to correlate 
with disease. 
The global distribution of S. suis STs also varies geographically and information 
on this distribution is largely limited to SS2 and SS9, which are of both animal and public 
health significance. ST1 (CC1) is the predominant SS2 ST isolated from diseased pigs 
and human cases in Europe and Asia (Goyette-Desjardins et al., 2014). ST7 (CC1) is the 
predominant cause of human infections in China, including the 2005 outbreak (Ye et al., 
2008), while ST20 is an important cause of human infections in the Netherlands (Schultsz 
et al., 2012). ST25 and ST28 (both CC28, previously CC27) are the most prevalent STs 
among North American strains, although differences in distribution exist between Canada 
and the United States (King et al., 2002; Fittipaldi et al., 2011). Fittipaldi et al. (2011) 
determined that 95% of SS2 porcine isolates from North America belonged to STs 25 and 
28, with 59% of Canadian and 75% of U.S. isolates belonging to ST25 and ST28, 
respectively (Fittipaldi et al., 2011). Virulence studies of different STs of SS2 
demonstrated that the epidemic Chinese ST7 strain was more virulent than virulent 
European ST1 strains (Ye et al., 2009; Lachance et al., 2013). North American ST25 
strains were intermediately virulent in a mouse infection model (Fittipaldi et al., 2011). 
Furthermore, Eurasian ST28 strains induced high rates of meningitis in mice while most 
North American ST28 strains were essentially avirulent/nonvirulent (Fittipaldi et al., 
2011; Auger et al., 2016a). SS9 is strongly associated with invasive disease in European 
swine herds, and 89-95% of clinical SS9 strains were previously characterized as ST16 
(CC16) (Schultsz et al., 2012; Willemse et al., 2019). SS7 ST29 strains were reported as 
an emerging S. suis pathotype in Europe (Rieckmann et al., 2018). ST1/CC1 and ST25, 
ST27 and ST28 (all CC28) have also been isolated from pig and human cases in 
Australia, Japan, and Thailand (Takamatsu et al., 2008b; Onishi et al., 2012; O’Dea et al., 
2018). 
Other standard molecular techniques 
Other standard molecular techniques utilized for describing the genetic diversity 
of S. suis include pulse-field gel electrophoresis (PFGE) (Berthelot-Hérault et al., 2002; 
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Vela et al., 2003), randomly amplified polymorphic DNA (RAPD) (Chatellier et al., 
1999; Cloutier et al., 2003), amplified fragment length polymorphism (AFLP) (Rehm et 
al., 2007), polymerase chain reaction-restriction fragment length polymorphism (PCR-
RFLP) (Marois et al., 2006), multilocus variable number tandem repeat analysis (MLVA) 
(Li et al., 2010b), and ribotyping (Harel et al., 1994; Okwumabua et al., 1995). Selection 
of molecular epidemiological tools is influenced by reproducibility, discriminatory 
power, ease of use and interpretation, cost, and universal applicability (Hatrongjit et al., 
2020). These techniques have provided valuable information into the epidemiology of S. 
suis. Genetic heterogeneity of S. suis was observed between and within swine herds with 
the prevalence and potential persistence of a few genotypes/clones responsible for a large 
proportion of clinical cases (Cloutier et al., 2003; Vela et al., 2003). Outbreak 
investigations, such as the analysis of isolates from the 1998 and 2005 Chinese outbreaks 
(Li et al., 2010b), provided molecular evidence of transmission of S. suis. Furthermore, 
the relationships between isolates from pigs of different clinical status (diseased vs 
healthy) (Okwumabua et al., 1995; Berthelot-Hérault et al., 2002; Cloutier et al., 2003; 
Marois et al., 2006; Rehm et al., 2007), host (human vs pig) (Chatellier et al., 1999; 
Berthelot-Hérault et al., 2002; Marois et al., 2006), and geographical region (Chatellier et 
al., 1999) were evaluated.  
Virulence factors and markers 
 A growing list of putative virulence-associated factors (virulence factors and 
markers) has been proposed for S. suis. Putative virulence factors and markers include 
surface and secreted proteins, enzymes/proteases, and inflammatory factors that are 
involved at different steps of pathogenesis (see in-depth reviews (Baums and Valentin-
Weigand, 2009), (Fittipaldi et al., 2012), (Feng et al., 2014), (Segura et al., 2017), (Tram 
et al., 2021)). Four important virulence-associated factors of S. suis are the capsular 
polysaccharide (CPS, cps gene loci), which is generally accepted as a virulence factor, 
and extracellular protein factor (EF, epf gene), muramidase-released protein (MRP, mrp 
gene), and suilysin (SLY, sly gene), which are considered "classical" virulence markers. 
As described above (see Serotyping section), SS2 strains are the most prevalent serotype 
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worldwide and are generally virulent in both pigs and humans. As a result, candidate 
virulence factors were mostly evaluated using SS2 (ST1 and ST7) experimental models. 
 The S. suis CPS plays an important role in the development of systemic and CNS 
disease, such as protecting against phagocytosis (see Pathogenesis section). However, up 
to 89% of nontypeable S. suis strains recovered from diseased pigs were reported as 
poorly or non-encapsulated (Bonifait et al., 2010; Gottschalk et al., 2013). In addition, 
non-encapsulated strains have been isolated from cases of porcine endocarditis indicating 
that certain non-encapsulated strains may also be virulent (Lakkitjaroen et al., 2011, 
2014). 
Suilysin (haemolysin) is a thiol-activated toxin and has high similarity with the 
pneumolysin toxin produced by the human pathogen S. pneumoniae (Segers et al., 1998). 
Invasive Eurasian strains are predominantly positive for suilysin (Segers et al., 1998; 
King et al., 2001). Suilysin-positive strains may promote invasion of mucosal epithelial 
cells and BMECs (BBB) through cytotoxic effects (see Pathogenesis section) 
(Tenenbaum et al., 2016). Moreover, immunization with SLY protected mice (Du et al., 
2013) and partially protected pigs (Jacobs et al., 1996) against SS2 challenge. However, 
the lack of suilysin in various disease-associated strains, especially North American 
strains (Segers et al., 1998; Fittipaldi et al., 2009; Gottschalk et al., 2013), indicates 
suilysin should be considered an important "virulence marker" as opposed to a "virulence 
factor." 
 MRP and EF are surface/secreted proteins with variants of different molecular 
weights (Silva et al., 2006). SS2 strains of the MRP+/EF+ phenotype induced specific 
clinical signs of S. suis disease (lameness or CNS signs) in pigs while strains of the 
MRP+/EF- and MRP-/EF- phenotypes induced nonspecific or no clinicals signs, 
respectively (Vecht et al., 1992). Wei et al. (2009) observed similar levels of virulence 
(high mortality) in mice by SS2 strains with the mrp+/epf+/sly+ genotype (Wei et al., 
2009). Invasive Eurasian strains are predominantly positive for MRP and EF (Wisselink 
et al., 2000; Wei et al., 2009), while invasive North American strains are predominantly 
MRP (or its variants)+/EF- or MRP-/EF- (Gottschalk et al., 2007; Fittipaldi et al., 2009), 
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although a high proportion of MRP+/EF+ strains was previously reported in the United 
States (Galina et al., 1996). Inactivation of the mrp and epf genes (SS1 and SS2) had no 
significant effect on virulence in pigs (Smith et al., 1996) but the deletion of mrp (SS2) 
reduced brain bacterial loads and histopathological signs of meningitis in infected mice 
(Wang et al., 2015). Together these results suggest that MRP and EF are virulence 
markers of S. suis.  
While significant progress has been made in identifying S. suis virulence factors, 
the definition of "virulence" and "virulence factor" is controversial. Strains may be 
classified as virulent or avirulent based on the clinical condition of the animal (clinically 
healthy or diseased) from which the strain was isolated or based on experimental 
infection models (Gottschalk and Segura, 2000). Virulence may also be assigned based 
on the presence of virulence-associated factors. However, the criteria and results are 
variable across research groups. For instance, variations in experimental design (strain 
serotype and/or ST, route of infection), in vitro models (cells or blood of porcine vs 
mouse or human origin), and animal models (mouse vs pig) contribute to inconsistent 
results on virulence (Gottschalk et al., 1999; Segura et al., 2017). Intravenous 
inoculations reproduce systemic disease (high morbidity and mortality) but are not 
appropriate models for investigating virulence factor candidates involved in the initial 
steps of colonization and mucosal invasion (Segura et al., 2016). Intranasal S. suis 
inoculation of pigs would be preferable as a "natural" route of infection but results in no 
or limited disease (Pallarés et al., 2003). Several recommendations, such as use of 
standardized models for defining virulence and shared reference strains across research 
laboratories, have been made to address the problems observed with S. suis virulence and 
the discovery of S. suis virulence factors (Gottschalk and Segura, 2000). 
Whole-genome sequencing 
Advances in next generation sequencing technologies and generation of large 
amounts of data led to numerous programs and software tools for bacterial 
characterization (Carriço et al., 2013). The use of these WGS-based approaches to 
complement detailed clinical data has been instrumental in the development of subtyping 
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tools for differentiating commensal and diseased-associated (systemic and/or respiratory) 
strains and for the identification of virulence markers of S. suis. CGH analysis of 55 S. 
suis isolates demonstrated the genomic similarity of SS1 and SS2 isolates originating 
from Canada, the Netherlands, China, and Vietnam, and isolated from both human and 
pigs (Cluster A) (de Greeff et al., 2011). These isolates correlated with ST1/CC1 and the 
MRP+/EF+ genotype which is typical of virulent strains. On the other hand, Cluster B 
was mostly composed of SS7 and SS9 with low inter- and intragenic similarity and 
isolates with an MRP-/EF- genotype. Zheng et al. (2014) described the classification of 
39 European, Chinese, and Canadian (human and porcine) isolates into three CGH groups 
of varying virulence: epidemic and highly virulent (E/HV), virulent (V), and 
intermediately or weakly virulent (I/WV) (Han Zheng et al., 2014, p. 201). The E/VH 
group largely consisted of SS2, ST1, and ST7, and the V and I/WV groups contained a 
diverse set of STs. The virulence of representative isolates was verified in vitro and in 
vivo (murine model).  
A minimum core genome (MCG) typing system for S. suis classified isolates into 
seven MCG groups based on group-specific SNP sites (Chen et al., 2013). Zheng et al. 
(2014) reduced the number of single nucleotide polymorphisms (SNPs) needed to 
identify the seven MCG groups from 553 to 10 SNPs, providing a more practical, rapid, 
and cost-effective assay for use in laboratories (H. Zheng et al., 2014). Only MCG group 
1 contained isolates from human infections and outbreaks, such as ST1 and ST7, and 
possessed the greatest number of virulence-associated genes (Chen et al., 2013). MCG 
groups 6 and 7 appeared to have the lowest virulence because they carried the least 
number of genes and a majority of the isolates from healthy pigs. 
A Bayesian Analysis of Population Structure (BAPS) of 98 S. suis isolates from 
human cases and diseased pigs in the Netherlands was utilized to explore differences in 
zoonotic potential between isolates (Willemse et al., 2016). In the study, BAPS groups 4 
(CC1) and 6 (CC20) were determined to have zoonotic potential, which was supported by 
a significant presence of virulence-associated genes in these isolates compared to the 
other 4 BAPS groups. Comparative genomic analysis of 375 human and porcine isolates 
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from the United Kingdom and Vietnam was able to differentiate isolates by clinical 
phenotype (systemic, respiratory, and non-clinical), and revealed a trend of genome-
reduction (smaller genomes) but an over-representation of virulence-associated genes in 
systemic isolates (Weinert et al., 2015).  
Long-read sequencing technology generate reads longer than 10Kb producing 
more contiguous genome assemblies (Amarasinghe et al., 2020). MinION nanopore 
sequencing of pathogens of veterinary importance is relatively new and its advantages 
include high mobility, low cost, and rapid turnaround. MinION sequencing was able to 
accurately predict the STs and antimicrobial resistance profiles of 8-10 of the S. suis 
isolates tested, demonstrating the potential use of MinION as a diagnostic tool for the 
characterization of pathogens (Tan et al., 2020). Bioinformatic analyses have also aided 
in the identification of candidate vaccine proteins against S. suis for subsequent 
evaluation in vaccine trials. For example, bioinformatics analyses can be applied to 
determining origin and conservation of candidate genes or proteins (Brockmeier et al., 
2018; Feng et al., 2018), determining amino acid sequence and tertiary structure (Zhang 
et al., 2014), and predicting subcellular location and identifying protective antigen 





Table 1.1 Worldwide distribution of major S. suis serotypes and sequence types (STs) involved in swine clinical cases 
 
Country  Serotypes STs References 
North America 
 
   
 
Canada 1/2, 2-4, 7, 8 25, 28 (SS2) (Goyette-Desjardins et al., 2014; Gottschalk and Lacouture, 2015) 
 
United States 
1/2, 2, 3, 6-8 25, 28 (SS2) (Fittipaldi et al., 2009; Goyette-Desjardins et al., 2014) 
South America 
 
   
 
Brazil 1-3, 1/2, 7, 14  (Goyette-Desjardins et al., 2014; Calderaro et al., 2016; Matajira et al., 2019) 
 
Argentina 2 1 (SS2) (Callejo et al., 2016; Doto et al., 2016) 
Europe 
 
   
 
Germany 
1, 2, 1/2, 7, 9, 14 
1 (SS2) 
29 (SS7) 
(Wisselink et al., 2000; Goyette-Desjardins et al., 2014; Prüfer et al., 2019) 
 
The Netherlands 
2, 7, 9 
1, 20 (SS2) 
16 (SS9) 
(Goyette-Desjardins et al., 2014; Willemse et al., 2019) 
 
Spain 
2, 7, 9 
1 (SS2) 
123, 125 (SS9) 









(Scherrer et al., 2020) 
 
Belgium 1, 2, 9, 14  (Wisselink et al., 2000) 
 
Denmark 2, 7  (Wisselink et al., 2000, p. 200) 
 
France 1-3, 7, 9 1 (SS2) (Wisselink et al., 2000; Goyette-Desjardins et al., 2014) 
 




1 (SS2, SS14) 
29 (SS7) 
(Wisselink et al., 2000; Goyette-Desjardins et al., 2014) 
 
Sweden 5, 11, 15, NT  (Werinder et al., 2020) 
Asia 
 
   
 
China 
2, 3, 4, 7, 9 
1, 7, 28, 117 (SS2) 
29, 117, 242, 243 
(Goyette-Desjardins et al., 2014; Zhang et al., 2019; Peng et al., 2020) 
 
South Korea 2, 1/2, 3, 8, 9  (Goyette-Desjardins et al., 2014; Gurung et al., 2015; Oh et al., 2017) 
 
Japan 2 1, 28 (SS2) (Goyette-Desjardins et al., 2014) 
Australia 
 
2, 1/2, 3 
1 (SS1/2) 
25, 28 (SS2) 
27 (SS3) 
 




Table 1.2 Potential markers of virulence for major S. suis serotypes and STs 
 
Serotypes Potential markers of virulence References 
2 
mrp, epf, sly: 
epf+/mrp+/sly+ (ST1), epf-/mrp-/sly- (ST25), epf-/mrp*/sly+/- (ST28) 
(Silva et al., 2006; Li et al., 2010b) 
 
pilus clusters: 
srtBCD+/srtF+ (ST1), srtF-/srtG+ (ST25), srtF+/srtG+ (STs 27, 28) 
(Takamatsu et al., 2009; Fittipaldi et al., 
2011; Onishi et al., 2012) 
 
ofs: 
type-1 ofs (CC1), type-3 and 4 ofs (CC27) 
(Takamatsu et al., 2008a) 
 rgg, endoD, SMU_61-like and SpyM3_0908 (Dong et al., 2015) 
9 mrp*/epf−/sly+ (Zheng et al., 2018) 
 
cps9, cpsK, fbps, manN, gapdh, virB4, virD4, sao, revS, SSU0207, 
SSU1589, SSUST30534 
(Dong et al., 2017; Zheng et al., 2018; 
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Streptococcus suis is a significant cause of mortality in piglets and growing pigs 
worldwide. The species contains pathogenic and commensal strains, with pathogenic 
strains causing meningitis, arthritis, endocarditis, polyserositis, and septicemia. 
Serotyping and multilocus sequence typing (MLST) are primary methods to differentiate 
strains, but the information is limited for strains found in the United States. The objective 
of this study was to characterize the diversity of 208 S. suis isolates collected between 
2014 and 2017 across North America (mainly the United States) by serotyping and 
MLST and to investigate associations between subtype and pathotype classifications 
(pathogenic, possibly opportunistic, and commensal), based on clinical information and 
site of isolation. Twenty serotypes were identified, and the predominant serotypes were 
1/2 and 7. Fifty-eight sequence types (STs) were identified, and the predominant ST was 
ST28. Associations among serotypes, STs, and pathotypes were investigated using odds 
ratio and clustering analyses. Evaluation of serotype and ST with pathotype identified a 
majority of isolates of serotypes 1, 1/2, 2, 7, 14, and 23 and ST1, ST13, ST25, ST28, 
ST29, ST94, ST108, ST117, ST225, ST373, ST961, and ST977 as associated with the 
pathogenic pathotype. Serotypes 21 and 31, ST750, and ST821 were associated with the 
commensal pathotype, which is composed of isolates from farms with no known history 
of S. suis-associated disease. Our study demonstrates the use of serotyping and MLST to 
differentiate pathogenic from commensal isolates and establish links between pathotype 
and subtype, thus increasing the knowledge about S. suis strains circulating in the United 
States. 
Keywords MLST, Streptococcus suis, multilocus sequence typing, pathogenic, 





Disease caused by Streptococcus suis is a significant economic and welfare 
concern in the swine industry. S. suis is a Gram-positive bacterium, and the species 
contains pathogenic and commensal strains. Pathogenic S. suis strains are associated with 
meningitis, arthritis, endocarditis, polyserositis, and septicemia in piglets and growing 
pigs (Clifton-Hadley, 1984; Reams et al., 1994), and S. suis strains isolated from 
neurological or systemic tissues (brain/ meninges, joints, and heart) are commonly 
considered the primary pathogens (Galina et al., 1992; Reams et al., 1994; Weinert et al., 
2015). Commensal strains normally reside in the upper respiratory tract of pigs, with pigs 
commonly serving as carriers (Clifton-Hadley and Alexander, 1980; Arends et al., 1984; 
Clifton-Hadley, 1984). S. suis can be an opportunistic pathogen associated with 
coinfections with other bacterial and viral pathogens (Galina et al., 1992; Reams et al., 
1994). In addition, some S. suis strains have zoonotic potential, causing meningitis in 
humans (Gottschalk et al., 2007). 
Serotyping and multilocus sequence typing (MLST) are commonly used to 
differentiate S. suis strains, and numerous subtypes exist within the S. suis species. 
Traditionally, serotyping uses the coagglutination test with reference antisera to subtype 
S. suis strains, and 35 known S. suis serotypes (1 to 34 and 1/2) exist. Six of those 
serotypes have been reclassified as Streptococcus orisratti (serotypes 32 and 34), 
Streptococcus parasuis (serotypes 20, 22, and 26), or Streptococcus ruminantium 
(serotype 33) (Hill et al., 2005; Tien et al., 2013; Tohya et al., 2017). The development of 
PCR-based and whole-genome sequencing (WGS) techniques can also be used to 
serotype and identify strains that were previously nontypeable through traditional 
serological methods (Kerdsin et al., 2014; Athey et al., 2016). 
A 1992 United States study investigated the serotype distribution of S. suis in 
porcine samples from Minnesota and reported the prevalence of serotypes 2 to 9 and 11, 
of which serotype 2 was the predominant serotype associated with neurological disease 
(Galina et al., 1992). A 1993 U.S. study identified serotypes 1 to 8 and 1/2 in naturally 
infected pigs primarily from a single state, with serotype 2 being the predominant 
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serotype, followed by serotypes 3, 4, 7, 8, 1, 5, 1/2, and 6 (Reams et al., 1993). A large 
U.S. study in 2009 investigated the serotype distribution of S. suis strains collected from 
2003 to 2005 from 17 states, illustrating that the distribution of strains was similar to 
Canada (Fittipaldi et al., 2009). In both countries, serotypes 1/2, 2, 3, 7, and 8 were most 
prevalent in diseased pigs (Messier et al., 2008; Fittipaldi et al., 2009) which is dissimilar 
to the distribution in Europe, in which serotype 2 occurs at a considerably higher 
percentage of isolates than in North America (Wisselink et al., 2000). 
MLST is a nucleotide sequence-based technique for subtyping bacteria, and a 
standard MLST scheme has been developed for S. suis, with 1,161 registered sequence 
type (ST) profiles as of 28 February 2019 (King et al., 2002) (pubmlst.org). Global 
MLST studies of S. suis identified ST1, ST25, and ST28 as the most prevalent STs in 
swine (de Greeff et al., 2011; Onishi et al., 2012; Schultsz et al., 2012; Zhu et al., 2013). 
In North America, ST25 and ST28 are more common among strains recovered from 
diseased animals, while ST1 strains are more prevalent in Europe and Asia (de Greeff et 
al., 2011; Fittipaldi et al., 2011; Schultsz et al., 2012). However, these studies address 
MLST for serotype 2 strains and may not apply to the remaining serotypes. 
Previously, studies have classified isolates into pathotypes based on clinical 
information and site of isolation (Galina et al., 1992; Weinert et al., 2015). Our objective 
was to combine information on pathotype with serotype and ST to address the limited 
information on current S. suis strains circulating within the United States. In total, 208 
porcine S. suis isolates from North America were characterized by serotyping and MLST 
to determine the population and distribution of S. suis in the United States. Furthermore, 
the serotype and MLST data were used to investigate associations with the pathogenic 
and commensal pathotypes with the goal to identify pathogenic- and commensal-specific 
serotype and MLST patterns. Identifying the major disease-causing strains can promote 
the development of treatment and control plans. Our research seeks to identify pathogenic 
strains to track isolates in an outbreak, select strains for a vaccine, and develop effective 
treatment and control plans. 
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2.3 Materials and methods 
2.3.1 Selection of S. suis isolates 
A total of 208 S. suis isolates were selected for the project. Most of the S. suis 
isolates were obtained from routine diagnostic cases submitted between April 2014 and 
July 2017 to the University of Minnesota Veterinary Diagnostic Laboratory (UMNVDL) 
or the Kansas State Veterinary Diagnostic Lab (KSVDL). Further commensal isolates 
were collected from 9 different farms with a lack of systemic S. suis clinical disease. 
Isolates that met our pathotype criteria (defined below) were selected from as many states 
as possible (n = 20) to minimize sample bias and increase geographic diversity to 
represent the major regions of the U.S. swine industry. S. suis isolates were verified to the 
species level by matrix-assisted laser desorption ionization–time of flight mass 
spectrometry (MALDI-TOF MS) (Microflex device, Bruker Daltonics GmbH, Germany) 
(Pérez-Sancho et al., 2017). 
Multiple isolates may be recovered from healthy pigs due to the native microflora 
of the upper respiratory tract, while a single isolate is generally responsible for systemic 
infections (Staats et al., 1997). To limit the bias in isolating and selecting strains 
associated with clinical signs, a pathotype category system was developed for the S. suis 
isolates similar to previously published methods (Higgins et al., 1992; Weinert et al., 
2015). “Pathogenic” isolates were obtained from the brain/meninges, joint, heart, or liver 
and reported as the primary cause of meningitis, arthritis, epicarditis, or septicemia in 
diagnostic reports by pathologists. “Possibly opportunistic” isolates were from lung 
samples submitted to the diagnostic lab from pigs without signs of neurological or 
systemic disease and included two isolates from nasal samples from farms with a clinical 
outbreak of S. suis disease. “Commensal” isolates were from laryngeal, tonsil, or nasal 
samples retrieved from farms with no known history or current control methods for S. 
suis disease. 
2.3.2 Serotyping, MLST via whole-genome sequencing 
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Isolates were recultured for 24 to 48 h at 37°C on blood agar plates (tryptic soy 
agar [TSA] with 5% sheep blood) (Thermo Fisher Scientific, Waltham, MA, USA) and 
sent for serotyping to the bacterial serology laboratory at the Diagnostic Service of the 
Faculty of Veterinary Medicine of the Université de Montréal, Canada. The serotyping 
was done through the coagglutination test with reference antisera (Gottschalk et al., 1989; 
Marcelo Gottschalk et al., 1991; M. Gottschalk et al., 1991; Higgins et al., 1995). 
Nontypeable samples (samples which failed to react with the serum panel, 
autoagglutinated, or reacted to several sera) were further serotyped by PCR (Okura et al., 
2014), a technique that cannot differentiate serotype 2 from 1/2 and serotype 1 from 14. 
The S. suis DNA was extracted using the protocol for cultured cells from the 
QIAamp DNA kit (Qiagen Inc., Germantown, MD, USA) and submitted to the University 
of Minnesota Genomic Center (UMGC, St. Paul, MN, USA) for library preparation using 
Nexture TX (Illumina, San Diego, CA), and next-generation sequencing was performed 
on a HiSeq 2500 instrument (Illumina) with 250-bp paired-end reads. Illumina 
sequencing reads for each isolate were processed using Trimmomatic (Bolger et al., 
2014) with an average quality cutoff of 20 (2.3 million average reads per sample). Strains 
were again confirmed as S. suis by having a 96.6% to 100% nucleotide identity to the 
1,662-bp S. suis-specific recombination/repair protein (recN) sequence (Streptococcus 
suis 05HAS68, GenBank accession number CP002007) using the S. suis serotyping 
pipeline (Ishida et al., 2014). 
The isolates with serotypes 2 or 1/2, 1 or 14, or lacking a subtype using traditional 
serotyping or PCR methods were serotyped using the WGS data and the S. suis 
serotyping pipeline (https://github.com/ streplab/SsuisSerotyping_pipeline) (Athey et al., 
2016). The pipeline uses the cpsK gene (Streptococcus suis NSUI002, GenBank 
accession number CP011419) missense mutation at position 161 to differentiate serotypes 
2 and 1/2 and serotypes 1 and 14. Isolates undifferentiable by WGS were categorized as 
serotype “1or14” or NT (nontypeable) in the downstream analysis. 
In silico MLST analysis was performed using the Short Read Sequence Typing 
for Bacterial Pathogens (SRST2) program (http://katholt.github.io/srst2), which maps 
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reads to MLST references (Inouye et al., 2014). The ST allele sequences and profiles 
were obtained from the S. suis MLST database (https://pubmlst.org/ssuis/) (Jolley and 
Maiden, 2010). Novel ST allele sequences were confirmed by PCR amplification and 
Sanger sequencing of the aroA, cpn60, dpr, gki, mutS, recA, or thrA genes (King et al., 
2002). The primers used for the amplification and sequencing of the mutS gene were 
mutS forward (5'-AAGCAGGCAGTCGGCGTGGT-3') and mutS reverse (5'-
AGTACAAACTACCATGCTTC-3') as described (Rehm et al., 2007). STs were grouped 
into major clonal complexes (CCs) using the entire MLST database and the eBURST 
software (Feil et al., 2004). Groups were defined with the strict parameters for 
determining single-locus variants (match of 6 or more loci). The entire S. suis MLST 
database was displayed as a single eBURST diagram by setting the group definition to 
zero of seven shared alleles. 
2.3.3 MLST clustering analysis 
Alignments, sequence identity calculations, and construction of the MLST 
sequence identity heatmap for basic clustering analysis were performed with R software 
(v.3.4.3) (R Core Team, 2017) and R packages (Charif and Lobry, 2007; Day, 2012; 
Bodenhofer et al., 2015; Warnes et al., 2016). The concatenated sequences of the seven 
MLST alleles were aligned with MUSCLE (v.3.8.31) (Edgar, 2004), and sequence 
identities were calculated. The sequence identity scores were used to generate a heatmap 
based on Euclidian distances and neighbor joining clustering. 
2.3.4 Statistical analysis 
Basic data transformation and plotting for statistical analyses were performed 
using R software and R packages (Wickham, 2009, 2017; Chen et al., 2018). Ternary 
plots of subtypes and pathotypes were generated using the R package Ternary (v.1.0.2) 
(Smith, 2017). The pathotype boundaries were assigned and color-coded using 50% as a 
cutoff. Odds ratio (OR) analysis was used to test all pathotype-subtype combinations 
containing more than a single isolate, and 95% confidence intervals (CIs) were generated 
using Fisher’s exact test. For each combination, the 2 by 2 table was created comparing 
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that pathotype and subtype against all others. Similar 2 by 2 tables were generated for 
testing pathotype and serotype-ST-combinations by chi-square and Fisher’s exact tests. 
ORs greater than 1 with a 0.3 minimum lower limit were considered biologically 
significant. The minimum lower limit of 0.3 was calculated as the average lower limit 
among the combinations, is specific to our data set, and was selected for the identification 
of biologically meaningful relationships. An infinite (Inf) OR for a pathotype-subtype 
combination refers to a subtype that occurred in only one pathotype. The associations 
within and between types were investigated using multiple correspondence analysis 
(MCA), with the FactoMineR (v.1.41) and factoextra (v.1.0.5) packages (Lê et al., 2008; 
Kassambara and Mundt, 2017), by setting the serotype, ST, and pathotype as the three 
variables. 
2.3.5 Data availability 
The reads associated with the samples were deposited in the NCBI Sequence 
Read Archive under accession numbers SRR9123061 to SRR9123268 (see Table S2.1). 
2.4 Results 
2.4.1 Serotype and ST distributions of S. suis in the United States 
Characterization of S. suis isolates by serotyping and MLST 
A total of 208 S. suis isolates were characterized, of which 203 were from the 
United States, 4 from Canada, and 1 from Mexico (Fig. 2.1). The clinical history and 
tissue of origin of the isolates were used to determine the pathotype, and the 208 isolates 
were classified as pathogenic (n = 139), possibly opportunistic (n = 47), and commensal 
(n = 22) (Table 2.1). The recN segment from S. suis was identified in the whole-genome 
sequences of all the 208 strains (>99% coverage of the gene and 40× to 314× depth), 
indicating that the isolates were S. suis. 
Serotyping identified 20 different serotypes representing 94.2% of the strains, 
while 5.3% were nontypeable (indicated as NT) and 0.5% could not be differentiated 
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between serotype 1 and 14 (n = 1) by coagglutination, PCR, or WGS (see Table S2.2 in 
the supplemental material). The predominant serotypes were 1/2 (n = 54) and 7 (n = 23). 
In silico MLST analyses were performed on the WGS data, and the samples had 
an average depth of 155× across the seven loci. STs could not be determined for four 
isolates because one housekeeping gene necessary for MLST classification was not 
identified in these isolates (referred to as NF, see Table S2.1 in the supplemental 
material). Fifty-eight different STs were identified for the remaining 204 isolates, 
indicating high diversity among the isolates (see Table S2.3 in the supplemental 
material). Twenty of these STs were previously defined, while 38 were newly identified 
(961 to 969, 971 to 998, and 1001; n = 56). The predominant ST was ST28 (n = 52), 
followed by ST94 (n = 18), ST1 and ST108 (n = 17 each). 
Relationship between serotypes and STs 
The distribution of STs by serotype illustrated the diversity of the S. suis strains 
(Fig. 2.2). Fifteen of the 20 serotypes identified contained multiple STs, with the number 
of different STs within a single serotype ranging from 2 to 8. The predominant serotype 
1/2 contained three STs (ST28 [n = 44], ST961 [n = 8], and ST982 [n = 1]). Serotypes 8, 
14, 24, 28, and 29 contained a single ST each, namely, ST87, ST1, ST94, ST968, and 
ST972, respectively. However, serotypes 24, 28, 29, and 1or14 contained only a single 
isolate. 
Distribution of pathotypes by serotype and ST 
The distribution of S. suis pathotypes by serotype is shown in Fig. 2.3. Serotype 
1/2 contained the most pathogenic isolates (n = 45/54), followed by serotypes 7 (n = 
19/23), 2 (n = 14/17), and 1 (n = 11/ 11). Serotypes 1 and serotype 14 (n = 5) were 
composed entirely of pathogenic isolates. The distribution of pathotypes by ST is shown 
in Fig. 2.4. ST28 contained the most pathogenic isolates (n = 42/52), followed by ST1 (n 
= 17/17), ST94 (n = 14/18), and ST108 (n = 14/17), of which only ST1 was composed 
entirely of pathogenic isolates. Additional pathogenic STs included ST961 (n = 9/10), 
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ST977 (n = 7/9), and ST13 (n = 5/ 5). Twelve STs contained isolates only classified as 
commensal, with ST750 and ST821 containing more than a single commensal isolate. 
2.4.2 Associations among pathotypes, serotypes, and STs by analysis of proportions 
and OR 
Associations between pathotype and serotype 
Proportions and OR analyses were used to investigate pathotype associations with 
serotype for serotypes (proportions) or serotype-pathotype combinations (OR analysis) 
that contained more than one isolate. Between 80% and 100% of serotypes 1, 1/2, 2, 7, 
14, and 23 were classified as the pathogenic pathotype (Fig. 2.5A), and these associations 
were supported by OR analysis (Fig. 2.5B). In the ternary plot, serotypes 3, 5, and 9 
demonstrated a moderate association with the pathogenic pathotype, with 56% to 63% of 
isolates classified as pathogenic. However, the association between pathotype and 
serotype was not supported by OR analysis. OR analysis supported associations of 
serotypes 10 and 12 with the possibly opportunistic pathotype, with 67% of isolates 
classified as possibly opportunistic in the ternary plot. Serotypes 21 and 31, with 67% to 
80% of isolates classified as commensal in the ternary plot, were supported as commensal 
pathotypes by OR analysis. 
Associations between pathotype and ST  
Proportions and OR analysis were used to investigate pathotype associations with 
ST for STs (proportions) or ST-pathotype combinations (OR analysis) that contained 
more than one isolate. The ternary plot of the 58 STs (and the NF category) illustrated a 
clear differentiation by pathotype for all STs except ST87 and ST119 (approximately 
50% pathogenic) (Fig. 2.6A). Twelve STs and the NF category contained over 75% of 
isolates classified as pathogenic, including ST1, ST13, ST25, ST28, ST29, ST94, ST108, 
ST117, ST225, ST373, ST961, and ST977, which demonstrated the same associations by 
OR (Fig. 2.6B). ST969 had an association with the possibly opportunistic pathotype, 
which was supported by OR. The commensal pathotype demonstrated a strong 
association with ST750 and ST821, which was supported by OR analysis. 
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Odds ratio and MCA of pathotypes, serotypes, and STs 
Initially, OR was used to investigate the relationships between pathotype and 
serotype-ST-combinations, but significance relationships were lacking for the 
combinations (OR data not shown). Then, MCA was performed to analyze the possible 
relationships among all serotypes, STs, and pathotypes (Fig. 2.7). The first and second 
dimensions of the analysis only represent 6% of the data. The ellipses represent 95% of 
isolates in each pathotype. All the subtypes demonstrating a strong association with the 
pathogenic pathotype by OR analysis (Fig. 2.5 and 2.6) fell within the overlapping 95% 
ellipses for multiple pathotypes by MCA (Fig. 2.7). Five serotypes and 13 STs in the 
commensal pathotype lacked overlapping ellipses. Serotypes 21 and 31 lacked any 
isolates with the pathogenic pathotype (Fig. 2.3), while ST750 and ST821 contained only 
isolates with the commensal pathotype (Fig. 2.4). The limited representations of the 
MCA data (6% variance) and the overlapping ellipses indicate a lack of relationship 
between serotype, ST, and pathotype, highlighting potential confounding factors for 
predicting pathogenic isolates based on both serotyping and MLST together. Thus, the 
relationship between pathotype, serotype, and ST is lacking for the pathogenic and 
possibly opportunistic pathotypes. 
2.4.3 Associations between pathotype and MLST CC by analysis of proportions and 
OR 
Identification of S. suis CCs  
To investigate the population structure of our S. suis isolates by MLST, the STs 
were assigned into CCs defined by eBURST, using the entire S. suis MLST database and 
our 58 STs (Fig. 2.8 and Table S2.3). Using the stringent definition (six of seven shared 
alleles) for defining a CC, five CCs (CC1, CC28, CC94, CC104, and CC750) with a 
primary founder were identified from our set of STs. However, multiple STs (n = 30) did 
not form a CC or formed a CC without a primary founder (Table 2.2). The most diverse 
CC (CC94) contained isolates from 13 of the 28 STs assigned into CC, compared with 
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CC1, CC28, CC104, and CC750, which contained isolates from 4, 7, 1, and 3 STs, 
respectively. 
Associations between pathotype and CC  
Patterns between CC and pathotype were investigated by proportions and OR 
analysis. CC1, CC28, CC94, and CC104 were associated with the pathogenic pathotype, 
and the association was supported by OR analysis (Fig. 2.9). CC750 was associated with 
the commensal pathotype and was supported by OR analysis, with 83% of isolates 
classified as the commensal pathotype. The STs among the group of isolates lacking a 
CC did not associate with any pathotype. 
Associations among pathotypes, serotypes, and MLST by clustering analysis 
To investigate genetic relationships among the samples and possible associations 
among serotype, genotype, and pathotype classifications, the MLST allelic sequences 
were clustered, illustrating 75% to 100% nucleotide sequence identity (Fig. 2.10). The 
five main CCs were identifiable in the MLST sequence identity heatmap as clusters of 
genetically similar strains. CC28 contained the most isolates with the pathogenic 
pathotype (n = 58/70) (Table 2.2) and was mostly composed of ST28 (predominant ST, n 
= 52) belonging to serotype 1/2 (predominant serotype, n = 44) and serotype 2 (n = 8) 
(Fig. 2.10). CC28 also contained ST961 (n = 10) belonging to serotype 1/2 (n = 8) and 
serotype 2 (n = 2). MLST clustering analysis demonstrated clustering of CC28 and 
CC104, and the latter consisted of only three isolates with the pathogenic pathotype 
(serotype 7, ST225). 
CC1 was divided into two groups and clustered with CC750 and isolates without 
a CC. The first cluster of CC1 contained a concentration of isolates in the pathogenic 
pathotype (n = 17/28), while the second cluster contained 4 pathogenic isolates, 6 
possibly opportunistic isolates, and a single isolate with the commensal pathotype (Table 
2.2). The isolates within the first cluster of CC1 were predominantly characterized as ST1 
(serotype 1 [n = 7/17], serotype 2 [n = 5/17], and serotype 14 [n = 5/17]). Lacking a CC, 
the ST13 isolates (n = 5; serotype 1 [n = 4] and serotype 1or14 [n = 1]) clustered with 
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CC1 isolates, demonstrating a possible genetic relatedness to isolates of CC1 and the 
pathogenic pathotype. Serotypes 1, 2, and 14 and ST1 and ST13 were also associated 
with isolates of the pathogenic pathotype by proportions and OR. Inversely, CC750 (n = 
6) consisted of isolates with the commensal (n = 5) and possibly opportunistic (n = 1) 
pathotypes and was predominantly composed of isolates characterized as nontypeable (n 
= 5/6) and ST750 (n = 4/6). Interestingly, CC750 was closely related to the group of 
isolates lacking a CC (n = 31), which consisted of isolates with the commensal pathotype 
(n = 12/31, multiple serotypes and novel STs), providing further evidence for the 
association between CC750 and the commensal pathotype. 
CC94 was predominantly composed of isolates with the pathogenic pathotype (n 
= 43/60) but contained isolates with all three pathotypes (Table 2.2). The isolates within 
CC94 with the pathogenic pathotype were predominantly characterized as ST94 (n = 
14/43; serotype 7 [n = 10/14]), ST108 (n = 14/43; serotype 23 [n = 8/14]), and ST977 (n 
= 7/43; serotype 5 [n = 6/7]). Serotype 7 was the second-most predominant serotype and 
was associated with the pathogenic pathotype by proportions and OR. Clustering analysis 
identified CC1, CC28, CC104, and a subset of CC94 as corresponding to the pathogenic 
pathotype. Isolates within these CCs were predominantly characterized as serotypes 1, 
1/2, 2, 7, 14, and 23 and ST1, ST13, ST28, ST94, ST108, ST961, and ST977, providing 
further evidence of these subtypes corresponding to the pathogenic pathotype. 
Supplementary material  
Supplemental material for this chapter may be found at doi 10.1128/JCM.00377-19. 
2.5 Discussion 
S. suis is an important swine pathogen, often resulting in neurological and 
systemic disease caused by pathogenic strains. However, much is still unknown about the 
population structure of S. suis in the United States. In this study, we utilized serological 
and molecular typing techniques to investigate the serotype and ST distributions of U.S. 
isolates. Fourteen of the 20 S. suis serotypes identified in this study were recovered from 
pigs with clinical disease (n = 139). The predominant pathogenic serotypes identified in 
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this study were 1/2 (n = 45), 7 (n = 19), and 2 (n = 14), which have been previously 
identified as the predominant serotypes from diseased pigs in North America (Messier et 
al., 2008; Fittipaldi et al., 2009; Gottschalk et al., 2013; Goyette-Desjardins et al., 2014). 
While serotypes 2 and 3 are considered predominant pathogenic serotypes in North 
America, only 10.6% of the strains in our study were recovered from diseased pigs. 
Furthermore, the serotype distribution from our study differed from European studies, in 
which serotypes 2 and 9 are predominant (Vela et al., 2003; Goyette-Desjardins et al., 
2014). The higher prevalence of serotype 1/2 in North America could be due to a 
common evolutionary lineage with serotype 2. Genetic analysis by PCR-based serotyping 
of the cps loci demonstrated serotypes 1/2 and 2 share the same genetic profile and 
cannot be differentiated by serotype-specific cps loci (Kerdsin et al., 2014; Athey et al., 
2016). Sequencing of the cpsK gene reveals a missense mutation permitting the 
differentiation of serotypes 2 and 1/2 (Athey et al., 2016), but a PCR protocol has not 
been implemented yet to differentiate these serotypes. 
In our study, the geographic distribution of S. suis was from 20 different states 
(Table S2.1), which represent the major swine-producing states in the United States. 
Variability in the serotype distribution of S. suis has been reported within the same 
country, which is likely due to natural differences in geographic distribution (Reams et 
al., 1993). Geographic distribution of the S. suis serotypes in our study identified serotype 
1/2 in 13 of the 20 states, with a concentration in 5 of the 20 states, possibly displaying a 
geographic distribution pattern of serotype 1/2 in the United States. Serotype 1/2 is also a 
frequent serotype found in Canada, although at lower levels than serotypes 2 and 3 
(Gottschalk and Lacouture, 2015). This prevalence of serotype 1/2 in Canada may 
contribute to the U.S. serotype distribution through the transport of pigs between the two 
countries (Goyette-Desjardins et al., 2014). Transport of livestock has been associated 
with geographic invasion or the emergence of a pathogen in a novel geographic area 
(Pasma et al., 2008; Nelson et al., 2011; Lowe et al., 2014). While most transport of pigs 
to the United States head to harvest facilities, new breeding stock of pigs could be 
colonialized with new S. suis strains, which could result in the spread of new strains to 
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downstream swine farms. Whole-genome analysis of the U.S. and Canadian serotype 1/2 
strains would further clarify the relationship between U.S. and Canadian 1/2 strains. 
We anticipated identifying a large number of novel ST profiles due to the 
inclusion of commensal and possibly opportunistic samples, which are not generally 
subjected to subtyping by MLST. As a result of this study, 38 novel ST profiles were 
submitted to the S. suis MLST database. Of the 58 STs identified here, 24 STs were 
isolated from pigs with clinical disease, and the predominant STs were ST28 (n = 42), 
followed by ST1 (n = 17), ST94 (n = 14), and ST108 (n = 14). In a previous Canadian 
study in 2011, ST25 was the predominant ST found in Canada, while ST28 was the 
predominant ST found in the United States (Fittipaldi et al., 2011). Our results confirm 
ST28 as a predominant pathogenic pathotype, while ST25 represents only 1% of the 
strains recovered from diseased pigs (n = 2). The reason for this low percentage of ST25 
isolates in the United States is unclear, and updated ST analysis of S. suis strains from 
Canada is needed to confirm ST25 as the predominant ST in that country. Our ST 
distribution also differs from that of European and Asian countries in which ST1 strains, 
largely characterized as serotype 2, are predominant in diseased pigs (Goyette-Desjardins 
et al., 2014; Auger et al., 2016b). 
Proportions, OR, and clustering analysis illustrated potential relationships among 
pathotypes, serotypes, and STs. While multiple pathogenic serotypes and STs were 
identified in our study, this discussion focuses on serotype and STs with more than four 
isolates in the pathogenic pathotype. Serotypes 1, 1/2, 2, 7, 14, and 23 as well as ST1, 
ST13, ST28, ST94, ST108, ST961, and ST977 were frequently identified as pathogenic 
strains. Based on our pathotype classifications, isolates characterized as pathogenic were 
linked to neurological or systemic disease, and our analyses provide evidence that these 
subtypes are potential indicators of virulence. As discussed previously, serotypes 2 and 
1/2 are predominant serotypes identified from diseased pigs in North America, supporting 
our observations of these serotypes as pathogenic strains by proportions, OR, and 
clustering analysis (Messier et al., 2008; Fittipaldi et al., 2009; Gottschalk et al., 2013; 
Goyette-Desjardins et al., 2014; Gottschalk and Lacouture, 2015). 
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Serotypes 1 and 7 are more prevalent in diseased pigs in some European countries 
than in North America, and pathogenic serotype 1 strains have been linked to the 
production of muramidase-released protein (MRP), extracellular-factor protein (EF), and 
suilysin (SLY). Pathogenic serotype 1 strains have been characterized as producing both 
MRP and EF, with variable production of SLY (Wisselink et al., 2000; de Greeff et al., 
2011). In one study (de Greeff et al., 2011), four of the six serotype 1 strains were 
MRP+EF+SLY+ and five of the six were either ST1 or ST13, indicating a correlation 
between serotype 1, ST1, ST13, and virulence. Interestingly, the serotype 1 isolates in the 
current study were either ST1 (n = 7/11) or ST13 (n = 4/11) and were associated with the 
pathogenic pathotype, supporting the previous study. Serotype 7 was the second-most 
common serotype identified in this study, and 19/23 isolates were characterized as the 
pathogenic pathotype. Virulence studies on serotype 7 strains demonstrating clinical 
disease in pigs are limited, but a previous in vivo study associated serotype 7 with 
septicemia and arthritis, with rare cases of meningitis (Boetner et al., 1987). These 
findings support the classification of serotype 7 as pathogenic. 
This study demonstrates that ST appears to be a stronger predictor of pathotype 
than serotype. While experimental mouse models have demonstrated the virulence of 
serotype 2 ST1, ST25, and ST28 (Fittipaldi et al., 2011; Auger et al., 2016b), our 
analyses also illustrated ST1, ST13, ST28, ST94, ST108, ST961, and ST977 (of various 
serotypes) as pathogenic. As mentioned previously, we hypothesize that Canadian and 
U.S. serotype 2 and serotype 1/2 strains share a evolutionary lineage. If so, the observed 
virulence of serotype 2 ST28 in previous studies may support the virulence of serotype 
1/2 ST28, as predicted in our study. Whole-genome single nucleotide polymorphism 
(SNP)-based phylogenetic analysis S. suis serotype 2 ST28 strains revealed a unique 
clade composed of virulent strains capable of inducing severe disease in a murine 
infection model (Athey et al., 2015). These strains demonstrated differences in virulence 
to reference serotype 2 ST28 strains of low virulence. Recently, a study characterized 
pathogenic Australian serotype 1/2 ST1 strains by core genome single nucleotide 
polymorphisms and linked the genetic similarity to pathogenic serotype 1/2 ST1 strains 
from the United Kingdom and Vietnam (O’Dea et al., 2018). Our clustering analysis 
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indicates that ST1, ST13, ST94, ST108, ST961, and ST977 may also be pathogenic. It 
would be of interest to further investigate the virulence properties of serotype 1/2 ST28, 
as well as ST1, ST13, ST94, ST108, ST961, and ST977 strains isolated in the United 
States. 
In addition to strains in CC1, CC28, and CC104, serotype 9 strains belonging to 
CC16 (previously CC87) have been isolated from pigs with invasive disease (Schultsz et 
al., 2012). However, the low percentage of serotype 9 strains in our study is reasonable 
because serotype 9 is predominant in diseased pigs from the Netherlands (Wisselink et 
al., 2000). The serotype 9 strains in this study belong to multiple CCs or occur as 
singletons and did not demonstrate associations with pathotype. Serotype 9 isolates from 
diseased and healthy pigs in China were characterized into multiple STs and 
demonstrated high diversity among the isolates (Dong et al., 2017). The majority of these 
serotype 9 isolate STs occurred as singletons and did not form major clonal complexes. 
Inversely, commensal S. suis serotypes 21 and 31 and ST750 and ST821 were 
identified by proportions, OR, and cluster analysis. Studies on S. suis from North 
America have observed a prevalence of serotype 21 from healthy pigs (Gottschalk et al., 
1989; Marcelo Gottschalk et al., 1991). However, previous studies have identified a 
limited number of serotype 31 strains from pigs with typical clinical signs of S. suis 
disease (Gottschalk et al., 2013; Gottschalk and Lacouture, 2015; Wongsawan et al., 
2015; Prüfer et al., 2019). The association between serotype 31 and pathotype remains 
unclear and requires further investigation. 
Associations among serotypes, STs, and pathotypes, although identified by 
individual analyses, were not evident in the MCA, indicating both serotype and ST 
together could not indicate pathotype. We investigated additional approaches, such as 
chi-square and Fisher’s exact tests, but these tests failed to generate significant 
relationships between both serotype and ST. In addition, we investigated associations 
between serotype-ST combinations and pathotype by chi-square and Fisher’s exact tests 
and did not identify any significant associations. One possible explanation for this is the 
lack of discrimination due to the limitations of sample size within each subtype. 
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Traditional chi-square and Fisher’s exact tests work best on nonsparse data (few zero 
values) (Mielke and Berry, 2002; Sourial et al., 2010). These tests have been used to 
identify associations between S. suis subtypes and characteristics of pathogenicity. 
However, most studies involved a limited number of subtypes of interest, while our study 
focused on all serotypes and STs identified in our sample set. Due to the diversity of the 
S. suis strains in this study and the large number of subtypes evaluated, the division of 
our data by pathotype resulted in sparse data. Thus, sparse data limits our ability to 
conduct certain analyses using common approaches for S. suis. An OR formula was used 
to evaluate statistical significance of subtype with pathotype, as well as the size of the 
possible effect, to limit the misidentification of associations due to sample size. For this 
reason, proportions were used for basic identification of relationships and OR analysis 
was used for further discrimination of strains. 
In summary, our study increases the knowledge on S. suis strains circulating in 
the United States between 2014 and 2017 by investigating serotype and ST distributions. 
We identified a diverse set of strains, predominantly serotypes 1/2, 3, and 7, and as ST1, 
ST28, and ST94. Further investigation by pathotype classification (defined in this study) 
identified STs that could be differentiated as pathogenic or commensal pathotypes. The 
predominance of serotype 1/2 strains from clinically affected pigs in our study stresses 
the importance of expanding studies of virulence traits to other serotypes and STs of S. 
suis. These findings can be applied to improve the prevention and control of S. suis by 
selecting strains for diagnostics and vaccine development. 
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Figure 2.1 The number and percentage of S. suis isolates characterized from each 
state. States are colored according to the number of isolates characterized from each 
state. States without isolates are gray. Isolates from Canada (n = 4) and Mexico (n = 1) 










Figure 2.2 Distribution of S. suis STs by serotype. The stacked histogram illustrates the serotypes identified in this study, which 
were subdivided by STs. The x axis represents each serotype while the y axis represents the frequency of each serotype. Bar sections 
are labeled with their respective STs. The category 1or14 and (nontypeable (NT) represents isolates with serotypes that could not be 








Figure 2.3 Distribution of S. suis pathotypes by serotype. The stacked histogram illustrates the serotypes identified in this study, 
which were subdivided by pathotype (pathogenic, possibly opportunistic, and commensal). The x axis represents each serotype while 
the y axis represents the frequency of each pathotype. Bar sections are labeled with their respective pathotypes. The category 1or14 





Figure 2.4 Distribution of S. suis pathotypes by ST. The stacked histogram illustrates the STs identified in this study, which were 
subdivided by pathotype (pathogenic, possibly opportunistic, and commensal). The x axis represents each ST while the y axis 
represents the frequency of each pathotype. Bar sections are labeled with their respective pathotypes. Not found (NF) indicates ST 










Figure 2.5 Ternary and OR plots summarizing the associations between S. suis pathotype and serotype. Only serotypes 
containing more than a single isolate are illustrated in the ternary plot, and only pathotype-serotype combinations containing more 
than a single isolate are illustrated in the OR plot. (A) The proportions of isolates classified as the pathogenic, possibly opportunistic, 
and commensal pathotype in each of the 16 serotypes (and the NT category) were plotted. The gray lines and color shading denote 
pathotype boundaries. (B) OR plot for 16 serotypes (and the NT category) versus pathotype. The dotted lines illustrate the minimum 
lower limit (OR, 0.3) and typical threshold (OR, 1) for identifying significant ORs. Error bars represent the 95% confidence intervals. 











Figure 2.6 Ternary and OR plots summarizing the associations between S. suis pathotype and ST. Only STs containing more 
than a single isolate are illustrated in the ternary plot, and only pathotype-ST combinations containing more than a single isolate are 
illustrated in the OR plot. (A) The proportions of isolates classified as the pathogenic, possibly opportunistic, and commensal 
pathotype in each of the 17 STs (and the NF category) were plotted. The gray lines and color shading denote pathotype boundaries. 
(B) OR plot for 16 STs (and the NF category) versus pathotype. ST119 contained a single isolate of each pathogenetic and possibly 
opportunistic pathotype failing to meet the criteria for the plot. The dotted lines illustrate the minimum lower limit (OR, 0.3) and 
typical threshold (OR, 1) for identifying significant ORs. Error bars represent the 95% confidence intervals. Infinite (Inf) is 
represented by the value 10,000 for visualization purposes. Not found (NF) indicates ST could not be determined because one 










Figure 2.7 Three-way MCA analyzing the associations among pathotypes, serotypes, and STs. The ellipses represent 95% of 
isolates in each pathotype. Dots represent isolates colored by their respective pathotype, and hollow diamonds represent the three 
active variables (pathotype, serotype, and ST). Nontypeable (NT) represents isolates which could not be serotyped using 
coagglutination, PCR, or WGS. Not found (NF) indicates ST could not be determined because one housekeeping gene could not be 








Figure 2.8 eBURST illustration of the global S. suis population. Primary founders (blue) are positioned at the center of the cluster 
and subgroup founders are shown in yellow. Clusters of linked STs correspond to CCs. Magenta dots mark the STs identified in our 







Figure 2.9 Ternary and OR plots summarizing the associations between pathotype and CC. (A) The proportions of isolates 
classified as the pathogenic, possibly opportunistic, and commensal pathotype in each of the five CCs (and the noCC category) were 
plotted. The gray lines and color shading denote pathotype boundaries. (B) OR plot for all five CCs (and the noCC category) versus 
pathotype. The dotted lines illustrate the minimum lower limit (OR, 0.3) and typical threshold (OR, 1) for identifying significant ORs. 
Error bars represent the 95% confidence intervals. Infinite (Inf) is represented by the value 10,000 for visualization purposes. noCC 









Figure 2.10 MLST sequence identity heatmap of S. suis. Isolates are annotated 
(colored rectangles) by pathotype (1), serotype (2), and ST (3). The five CCs are 
indicated by black brackets, with the number of isolates in the CC. Blue brackets 
represent clusters of isolates without a CC. Nontypeable (NT) represents isolates which 
could not be serotyped using coagglutination, PCR, or WGS. #, group of isolates lacking 







Table 2.1 Distribution of S. suis isolates by pathotype classification and tissue of origin 
 
 
Pathotype Tissue of origin n 
Pathogenic (n = 139, 66.8%) Brain/meninges/spinal cord 56 
 Heart 25 
 Joint/synovial fluid 23 
 Liver 35 
Possibly opportunistic (n = 47, 22.6%) Lung 45 
 Nasal 2 
Commensal (n = 22, 10.6%) Laryngeal 1 
 Nasal 17 
 Tonsil 4 


























1 28 21 6 1 1, 17, 23, 87 
28 70 58 12 0 25, 27–29, 117, 961b, 973b 
94 60 43 14 3 94, 108, 119, 373, 839, 
962b, 964b, 966b, 969b, 
977b, 980–982b 
104 3 3 0 0 225 
750 6 0 1 5 750, 972b, 992b 
noCCc 37 11 14 12 13, 821, 948, 949, 963b, 
965b, 967b, 968b, 971b, 
974–976b, 978b, 979b, 
983–991b, 993–998b, 
1001b 
aSTs could not be determined for 4 of the 208 isolates because 1 housekeeping gene could not be identified 
for MLST classification. 
bNovel ST(s). 
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There is limited information on the distribution of virulence-associated genes (VAGs) in 
U.S. Streptococcus suis isolates, resulting in little understanding of the pathogenic 
potential of these isolates. This lack also reduces our understanding of the epidemiology 
associated with S. suis in the United States and thus affects the efficiency of control and 
prevention strategies. In this study we applied whole genome sequencing (WGS)-based 
approaches for the characterization of S. suis and identification of VAGs. Of 208 S. suis 
isolates classified as pathogenic, possibly opportunistic, and commensal pathotypes, the 
genotype based on the classical VAGs (epf, mrp, and sly encoding the extracellular 
protein factor, muramidase-release protein, and suilysin, respectively) was identified in 
9% (epf+/mrp+/sly+) of the pathogenic pathotype. Using the chi-square test and LASSO 
regression model, the VAGs ofs (encoding the serum opacity factor) and srtF (encoding 
sortase F) were selected out of 71 published VAGs as having a significant association 
with pathotype, and both genes were found in 95% of the pathogenic pathotype. The 
ofs+/srtF+ genotype was also present in 74% of ‘pathogenic’ isolates from a separate 
validation set of isolates. Pan-genome clustering resulted in the differentiation of a group 
of isolates from five swine production companies into clusters corresponding to clonal 
complex (CC) and virulence-associated (VA) genotypes. The same CC-VA genotype 
patterns were identified in multiple production companies, suggesting a lack of 
association between production company, CC, or VA genotype. The proposed ofs and 
srtF genes were stronger predictors for differentiating pathogenic and commensal S. suis 
isolates compared to the classical VAGs in two sets of U.S. isolates. Pan-genome analysis 
in combination with metadata (serotype, ST/CC, VA genotype) was illustrated to be a 
valuable subtyping tool to describe the genetic diversity of S. suis. 
Keywords Streptococcus suis, Virulence-associated genes (VAGs), Pathotype, Pan-




The severe clinical presentation associated with Streptococcus suis infection is of 
increasing concern in the U.S. swine industry. The heterogeneity of S. suis can be 
described by serotyping and multi-locus sequence typing (MLST), and currently 29 true 
serotypes (1–19, 21, 23–25, 27–31, and 1/2) and 1551 registered sequence type (ST) 
profiles (as of December 2020) exist (Higgins et al., 1995; King et al., 2002; Hill et al., 
2005; Tien et al., 2013; Jolley et al., 2018). The numerous S. suis serotypes and STs limit 
our attempts to understand the epidemiology of the disease in an effort to prevent and 
manage the various clinical manifestations. Further, S. suis has zoonotic potential, and 
many of the effective antibiotics available for treatment are of high or critically important 
status per U.S. Food and Drug Administration’s Guidance for Industry #152 (2003). 
Also, serotype variations make it difficult to compare isolates within and across 
geographically distinct pig populations. The development of effective universal vaccines 
is hindered by the number of different virulent serotypes and the lack of knowledge of 
serotype- or ST-specific virulence markers and associated clinical disease.  
Historically, systematic characterization of S. suis isolates occurred more 
extensively in other countries compared to the United States. For instance, serotypes 2, 3, 
and 1/2 have been well-characterized in Canadian swine populations (Higgins and 
Gottschalk, 2001; Messier et al., 2008; Gottschalk et al., 2013). In addition, virulence-
associated genes (VAGs) (epf, mrp, and sly) and STs indicative of virulence potential 
were identified, mostly for serotype 2 (Gottschalk et al., 2013, 1998; Fittipaldi et al., 
2011, 2009). Experimental studies illustrating the virulence potential of Canadian 
serotype 2 strains (ST1, ST25, and ST28) suggest the virulence potential of ST28 strains 
is low at best in Canada, but a very different clinical presentation was being observed on 
U.S. swine farms with ST28 (Fittipaldi et al., 2011; Athey et al., 2015; Auger et al., 
2016a). In the past 4 to 5 years, S. suis infections on U.S. swine farms appeared to be 
more persistent and severe (Leuwerke et al., 2019; Pig Health Today, 2019). However, 
whether this is a result of new circulating strains, an increase in virulence, or some other 
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cause is not well understood, reinforcing the importance of the characterization of S. suis 
to monitor changes in strains within a herd. 
U.S. swine practitioners utilize herd vaccination strategies as a means of 
controlling S. suis disease. However, selecting representative isolates and properly timing 
the administration of vaccines still remain a challenge (Baums et al., 2010). As a result of 
the diversity of S. suis, limited commercial vaccines are available, and many practitioners 
develop and maintain farm-specific autogenous vaccines. In addition, clear criteria for 
identifying pathogenic strains that cause primary disease are lacking, making isolate 
selection for vaccines more difficult (Segura et al., 2017). Isolates are commonly selected 
based on criteria such as serotype and isolation from systemic tissues (Galina et al., 1992; 
Reams et al., 1994). However, due to the diversity within and between serotypes, cross-
protection between, and even within, different serotypes is difficult to attain (de Greeff et 
al., 2011; Zhang et al., 2011; Quessy et al., 1994; Segura et al., 2020). Moreover, the 
presence of virulence markers is critical for selecting isolates for autogenous vaccines. 
Over 100 putative and confirmed virulence factors and markers (not crucial or critical for 
virulence) for S. suis have been described in the literature, but few have been verified in 
experimental models (Fittipaldi et al., 2012; Segura et al., 2017). These include Eurasian 
serotype 2 virulence markers extracellular protein factor (epf gene), muramidase-released 
protein (mrp gene), and suilysin (sly gene), which have been investigated in STs 1, 25, 
and 28 strains from North America (Gottschalk and Segura, 2000; Fittipaldi et al., 2011; 
Goyette-Desjardins et al., 2014). 
The application of genomic approaches to identify associations between VAGs 
and disease manifestation can lead to a better understanding of S. suis pathogenesis. 
However, a comparative genomic study investigating the current distribution of S. suis 
VAGs in U.S. isolates is lacking. Recently, we reported associations of various 
pathotypes with subtypes, including serotype and ST, of S. suis (Estrada et al., 2019). In 
this current study, a genomic approach was utilized to identify associations between 
VAGs and pathotype of U.S. isolates while evaluating the likelihood of classical Eurasian 
serotype 2 VAGs and newly proposed VAGs to identify pathogenic strains. In addition, 
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pan-genome genetic relationships, along with their VAG profiles (virulence-associated 
genotypes), were investigated for isolates within and between swine production 
companies. Finally, we applied the genomic approach for identifying associations 
between VAGs and pathogenicity classification to a validation set of S. suis isolates to 
determine whether our approach was robust enough to identify pathogenic strains isolated 
from other swine production companies. 
3.3 Materials and methods 
3.3.1 Source of isolates and collection of epidemiological data  
A training set of 208 S. suis isolates were used in this study. These isolates, 
previously described by Estrada et al. (2019), were classified into three pathotypes 
(pathogenic, possibly opportunistic, and commensal) based on clinical information and 
site of isolation. “Pathogenic” isolates were obtained from systemic tissues such as the 
brain/meninges and heart. “Possibly opportunistic” isolates were predominantly from 
lung samples from pigs without signs of neurological or systemic disease. “Commensal” 
isolates were from laryngeal, tonsil, or nasal samples retrieved from farms with no 
current control methods for S. suis disease. 
Furthermore, epidemiological data, such as swine production company and site, 
were collected for the training set of isolates. The swine production companies coded as 
A, D, E, K, and M are all large operations that range in size from 70,000 to 340,000 sows 
and with headquarters in the United States (A and D = MN, E = MO, K = KS, and M = 
IL). 
3.3.2 VAG profiling 
VAG profiling was performed on the training set using a custom database of 
previously published VAGs of S. suis (Table S3.1) (Estrada et al., 2019). Illumina 
sequencing reads were mapped to reference DNA sequences (≥ 60% coverage and ≥ 90% 
sequence identity) using the SRST2 (Short Read Sequence Typing for Bacterial 
Pathogens) program (Inouye et al., 2014). The construction of a presence and absence 
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heatmap (Euclidian distances and UPGMA clustering) was performed with R software (R 
Core Team, 2017). 
3.3.3 Statistical analysis 
Associations between published S. suis VAGs and pathotype, as previously 
defined by Estrada et al. (Estrada et al., 2019), were investigated. Published VAGs 
present in a majority of isolates (> 90%, 188/208) were removed. VAGs present in < 50% 
of the pathogenic pathotype (< 70/139) were also removed. Remaining VAGs were tested 
by chi-square, comparing the three pathotypes and the status (presence/absence) of 
individual genes. Genes lacking a significant (chi-square p-value < 0.05) association with 
pathotype were removed from the analysis. The remaining genes were analyzed using the 
Least Absolute Shrinkage and Selection Operator (LASSO) regression model (Tibshirani, 
1996). 
The LASSO regression model reduces coefficients to zero and gradually 
eliminates genes that have no or low correlation with the target variable. The LASSO 
model was used to determine VAGs that may serve as the ‘best’ predictors of 
pathogenicity, in this case using the pathogenic pathotype as the indicator of 
pathogenicity. The analysis was performed using the R package glmnet and the best 
lambda penalty value to determine the fewest number of predictor genes (Friedman et al., 
2010). Due to variation in the number of predictor VAGs in each run, we ran 100 
iterations of the LASSO model to determine the most relevant predictor genes. Predictor 
VAGs reported in all 100 iterations were considered relevant candidate VAGs. 
3.3.4 Genome assembly and pan-genome analysis 
Genome assembly was performed on Illumina sequencing data from the training 
set (Estrada et al., 2019): SRA accession numbers SRR9123061-SRR9123268. Genome 
assemblies were generated using MEGAHIT de-novo assembler (k-mer range of 25–225) 
and polished using Pilon (Walker et al., 2014; Li et al., 2016). QUAST was used to 
evaluate the genome assemblies (Gurevich et al., 2013). Only contigs that were 500 bp or 
larger were kept for annotation by Prokka to predict coding sequences (Seemann, 2014). 
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The pan-genome was annotated using Roary with a 90% BLASTp identity cut-off to 
define clusters of genes and allowing paralog clustering (Page et al., 2015; van Vliet, 
2017). The FastTree program was used to generate an approximately-maximum-
likelihood phylogenetic tree based on the binary presence and absence of core and 
accessory genes. Percent similarity was calculated as the percentage of shared genes in 
the pan-genome. 
3.3.5 Selection and whole genome sequencing of validation set 
Thirty-two isolates obtained from a single swine production company from 2017 
to 2019 were classified as either ‘pathogenic’ or of ‘unknown-pathogenicity’ based on 
tissue source (Table S3.2). Isolates classified as ‘pathogenic’ were obtained from the 
brain (n = 19). The isolates of ‘unknown-pathogenicity’ were isolated from non-systemic 
tissues (no neurological signs) (n = 13). The S. suis isolates were sequenced and the 
sequencing reads were processed using a similar method as described for the training set 
(Estrada et al., 2019). Isolates were confirmed as S. suis if they possessed the S. suis-
specific recombination/repair protein (recN) sequence (Streptococcus suis 05HAS68, 
Accession CP002007). 
3.3.6 Serotype, MLST, VAG profile, and pan-genome analysis of validation set 
The serotyping of the validation set of S. suis isolates was verified using a S. suis 
serotyping pipeline described by Athey et al. (2016) to differentiate serotypes 2 and 1/ 2 
and serotypes 1 and 14 (Athey et al., 2016). In-silico MLST analysis was performed 
using the SRST2 program, and the ST allele sequences and profiles obtained from the S. 
suis MLST database (Jolley et al., 2018). Novel STs were further grouped into major 
clonal complexes (CCs) as previously described (Estrada et al., 2019). Data on presence 
or absence of the classical VAGs (epf, mrp, and sly) was obtained for each of the 32 
isolates as described above for the training set. Similar genome assembly and pan-
genome analysis as described for the training set were performed on the 32 isolates. The 
number of gene clusters identified for the training and validation sets may differ due to 
gene duplication, pseudogenes, gene acquisition/loss, and other genomic variations, as 
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well as differences in the number of genomes included in the pan-genome analysis 
(Medini et al., 2005; Meng et al., 2017). 
3.3.7 Data availability 
The datasets generated and/or analyzed during the current study are available in 
the Sequence Read Archive. Illumina sequencing data from the training set (Estrada et 
al., 2019) were deposited under the accession numbers SRR9123061-SRR9123268. 
Illumina sequencing data from the validation set were deposited under the accession 
numbers SRR12964194-SRR12964227. The accession numbers from the validation set 
can also be found in Table S3.2. 
3.4 Results 
3.4.1 VAG profiling 
Distribution of the epf, mrp, and sly genes 
In our previous study of 208 S. suis isolates (referred to as the training set), 139, 
47, and 22 were classified as the pathogenic, possibly opportunistic, and commensal 
pathotype, respectively (Estrada et al., 2019). The training set was also characterized by 
determination of serotype, MLST, and CC. In the current study, the distribution of the 
epf, mrp, and sly genes was bioinformatically determined for the 208 isolates in the 
training set. These classical VAGs epf, mrp, and sly were identified in 20 (14.4%), 127 
(91.4%), and 77 (55.4%) isolates of the pathogenic pathotype, respectively (Table 3.1). 
The epf gene was predominantly present in serotypes 1, 2, and 14 and CC1 isolates while 
mrp and sly were distributed among a diverse set of subtypes. The epf, mrp, and sly genes 
were identified in 0 (0%), 6 (27.3%), and 4 (18.2%) isolates of the commensal pathotype, 
respectively (Table 3.2). We further investigated genotype combinations of the epf, mrp, 
and sly genes and their distributions in STs 1, 25, and 28 (Table 3.2). The predominant 
genotype in the pathogenic pathotype was epf−/mrp+/sly- (41.0%, 57/139) followed by 
epf−/mrp+/sly+ (36.0%, 50/139). A majority of the ST28 (94%) and both ST25 isolates in 
the training set possessed the epf−/mrp+/sly- genotype. The epf+/mrp+/ sly+ genotype 
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was identified in only 20 of the 139 isolates classified as the pathogenic pathotype. All 17 
ST1 isolates possessed the epf+/mrp+/sly+ genotype. In summary, a majority of isolates, 
even those of the pathogenic pathotype, lacked the three classical VAGs, but all the 
isolates containing the three VAGs were classified as pathogenic or ST1. 
Determining predictors of pathotype by VAG profiling 
Given the limited distribution of classical VAGs (epf and sly) among isolates in 
the pathogenic pathotype, the classical VAGs are not appropriate indicators of 
pathogenicity for non-serotype 2 S. suis isolates from the United States. Thus, a total of 
71 previously published S. suis VAGs (including epf, mrp, and sly) were investigated for 
the presence of alternative genes that may be indicators of pathogenic strains. Thirty-two 
(45%) VAGs were present in all genomes regardless of pathotype and were clearly not 
indicators of the pathogenic pathotype (Table 3.3 & Table S3.3). Five VAGs were absent 
in all of the isolates in the commensal pathotype. SalK and salR, which encode the 
SalK/SalR two-component signal transduction system (Li et al., 2008), were not detected 
in any of the isolates despite mapping to different reference sequences. 
Clustering analysis was used to determine if relationships between the presence of 
previously published VAGs and pathotype existed. The analysis of 71 VAGs identified 
three clusters (Cluster I-III), two of which associated with pathotype (Fig. 3.1 & Table 
S3.4). Cluster I consisted of isolates of all three pathotypes. Cluster II predominantly 
consisted of isolates from the pathogenic pathotype and lacked isolates from the 
commensal pathotype. Cluster III contained the majority of isolates from the commensal 
pathotype (73%). Isolates in the pathogenic cluster (Cluster II) were predominantly 
characterized as serotype 1/2 CC28. Serotype 1/14 CC1 isolates formed a subcluster of 
Cluster I which lacked isolates from the commensal pathotype. Clustering analysis also 
illustrated multiple candidate published VAGs for discriminating between pathotypes, 




We then performed statistical analyses to test for associations between VAGs and 
pathotype. Of the 71 published VAGs detected in the genomes, 16 were tested by chi-
square and 14 were considered significant (chi-square p < 0.05) (Table 3.3 & Table S3.5). 
The classical VAGs mrp and sly were considered significant by chi-square. The 14 VAGs 
that were significant by chi-square were further analyzed by the LASSO model. The sly 
gene was in the top ten VAGs identified by LASSO, but mrp was not [data not shown]. 
The LASSO model identified four other candidate VAGs associated with the pathogenic 
pathotype (Table 3.4). The VAGs ofs and srtF were present in over 95% (≥ 132/139) of 
isolates in the pathogenic pathotype and thus, the presence of both genes was tested as 
predictors of the pathogenic pathotype. Ninety-five percent (132/139) of the pathogenic 
pathotype contained both genes while only 23% (5/22) of the commensal pathotype 
contained both genes. 
3.4.2 Diversity of U.S. S. suis by pan-genome analysis 
Relatedness of 208 S. suis isolates by pan-genome analysis 
Pan-genome analysis of 208 S. suis genomes generated a pan-genome of 8373 
gene clusters and illustrated multiple clusters that corresponded to the five MLST CCs 
(CC1, CC28, CC94, CC104, and CC750) (Fig. 3.2) (Estrada et al., 2019). Isolates from at 
least sixteen swine production companies (A-P) (≥ 2 isolates each) were identified in the 
data set, with A (n = 13), D (n = 16), E (n = 18), K (n = 21), and M (n = 16) representing 
the five production companies with the most isolates in this study (predominant 
production companies). The most predominant CCs (CC1, CC28, and CC94) were 
identified in multiple production companies. CCs 1, 28, and 94 were identified in 12, 11, 
and 12 of the 16 production companies, respectively. 
Relatedness of isolates within the five predominant production companies 
The genetic relationships between pathogenic and possibly opportunistic isolates 
within a production company were investigated using pan-genome analysis for each of 
the five predominant production companies A, D, E, K, and M (Fig. 3.3). None of the 
isolates from these production companies were classified as the commensal pathotype 
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(Estrada et al., 2019). In addition, we explored associations between pan-genome clusters 
and genotypes of the classical (epf, mrp, and sly) and proposed pathogenic (ofs and srtF 
genes) VAGs. The isolates demonstrated various genotypes of classical VAGs, and a 
majority (96.4%) possessed the proposed ofs+/srtF+ genotype for predicting pathogenic 
strains. 
Due to the diversity of isolates within each production company, we investigated 
pan-genome clusters and genotypes for each predominant production company. The 
isolates originating from production companies A, E, and M were placed into two, one, 
and three clusters, respectively, and multiple singletons each and demonstrated an overall 
83.1–99.9%, 89.3–100% and 85.3– 99.9% similarity, respectively. A majority of the 
isolates originating from A and E (A = 54%, E = 72%), and many from M (50%) 
possessed the classical VAG mrp but lacked the epf and sly genes. The isolates 
originating from production companies D and K were placed into three clusters and 
multiple singletons each and demonstrated an overall 89.4–100% and 86.6.-99.9% 
similarity, respectively. Multiple isolates from D and K (D = 44%, K = 48%) possessed 
mrp and sly but lacked the epf gene. A few isolates from each production company (n =1 
from companies D, E, K, and M, n = 2 from company A) possessed all three classical 
VAGs epf, mrp, and sly. A majority of isolates in all five production companies (A = 
92.3%, D = 100%, E = 100%, K = 95.2%, M = 93.8%) possessed the proposed 
ofs+/srtF+ genotype, indicating the presence of both ofs and srtF genes are a better 
predictor of pathogenicity than the presence of the epf, mrp, and sly genes. 
Relatedness of commensal isolates 
We further investigated the genetic relationships between the 22 isolates of the 
commensal pathotype. An 82.6–99.9% similarity was observed, with isolates forming 
two large clusters and multiple sub-clusters (Fig. 3.4). Thirteen isolates lacked a CC, 
while one, three, and five isolates were assigned to CC1, CC94, and CC750, respectively. 
The CC1 and CC94 isolates possessed more VAGs than the other commensal isolates 
with all possessing mrp and sly, and both ofs and srtF, while a majority of commensal 
isolates (77.3%) lacked the classical and proposed pathogenic VAGs. 
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Characterization of the validation set of S. suis isolates 
A distinct validation set of 32 S. suis isolates was obtained from a single 
production company to perform pan-genome analysis and further test the novel proposed 
pathogenic genotype (ofs+/srtF+). These isolates were classified as either ‘pathogenic’ 
or of ‘unknown-pathogenicity.’ The pan-genome consisted of 7078 gene clusters among 
the 32 genomes, and these pan-genome clusters associated with the ‘pathogenic’ and 
‘unknown-pathogenicity’ classifications, as well as with virulence-associated genotypes 
(Fig. 3.5). Clusters c-f corresponded to the ‘pathogenic’ classification. Only the isolates 
in clusters e and f possessed the classical VAGs epf, mrp, and sly. Moreover, all the 
isolates in these two clusters possessed the proposed pathogenic ofs+/srtF+ genotype. A 
majority of the isolates in cluster d (67%) possessed the ofs+/srtF+ genotype. 
Cluster a and singletons g-n corresponded to the ‘unknown-pathogenicity’ 
classification (Fig. 3.5). A majority (86%) of the isolates in cluster a possessed the 
classical VAGs mrp and sly, but three isolates (43%) also possessed the proposed 
pathogenic genotype. A majority (75%) of the singletons g-n lacked both the classical 
and proposed VAGs. Two isolates possessed the proposed pathogenic genotype. The 
diversity and lack of VAGs in clusters g-n is similar to the diversity seen among the 
commensal pathotype, suggesting these isolates are commensal strains. 
Supplementary material  
Supplemental material for this chapter may be found at doi 10.1186/s40813-021-00201-6. 
3.5 Discussion 
In this study, 71 published S. suis VAGs (including the classical VAGs epf, mrp, 
sly) were evaluated to identify pathogenic isolates associated with systemic and 
neurological disease from the United States. Notably, VAGs ofs and srtF demonstrated 
stronger associations with the pathogenic pathotype than the other 69 VAGs, suggesting 
novel published VAGs associated with pathogenicity. A genotyping scheme consisting of 
these two genes (ofs+/srtF+ genotype) identified pathogenic isolates in a validation set of 
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S. suis isolates, demonstrating its potential application for predicting pathogenicity in 
other swine production companies. The genetic diversity of isolates within and between 
swine production companies was evaluated by pan-genome analysis, and important 
associations were observed among pan-genome clusters, CCs, and virulence-associated 
(VA) genotypes. 
Muramidase-released protein has been associated with enhanced survival of S. 
suis in human blood and an increase in blood-brain barrier permeability in mice while 
suilysin plays a role in the inflammatory response although neither of which have been 
described as being critical as virulence factors (Smith et al., 1996; Allen et al., 2001; Lun 
et al., 2003; Wang et al., 2015; Pian et al., 2016; Tenenbaum et al., 2016). The epf gene 
was identified in only 14% and the sly gene was identified in 55% of isolates in the 
pathogenic pathotype. The mrp gene was identified in 91% of the pathogenic pathotype 
and 27% of the commensal pathotype suggesting the classical VAG mrp continues to be 
an adequate identifier of pathogenic strains. The epf+/mrp+/sly+ genotype is correlated 
with S. suis clinical disease caused by European and Asian ST1 strains belonging to 
serotypes 1, 2, 9, and 14 (Wisselink et al., 2000; Wei et al., 2009; Goyette-Desjardins et 
al., 2014). The ST1 isolates in the training set had the epf+/mrp+/sly+ genotype, and the 
ST25 and ST28 isolates had the epf−/mrp+/sly- genotype, confirming the use of the 
classical VAGs for identifying virulent ST1 strains but the limited use for identifying 
ST25 and ST28 strains in North America (Fittipaldi et al., 2011). 
Various subtyping methods, including serotyping and MSLT, have been used for 
evaluating the genetic diversity of S. suis isolates and identifying patterns specific to 
clinical isolates. Pulsed-field gel electrophoresis (PFGE) has been used for evaluating the 
genetic diversity of S. suis serotype 2, 1/2, 3, 7, and 9 strains (Berthelot-Hérault et al., 
2002; Vela et al., 2003). Although PFGE has high discriminatory power, typing a large 
number of isolates is time consuming and labor intensive. Unique randomly amplified 
polymorphic DNA patterns have been recovered from S. suis isolates from diseased pigs 
and correlated with the production of virulence markers (Chatellier et al., 1999; Maneerat 
et al., 2013). However, these analyses were mainly focused on serotype 2 strains. 
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Multiplex PCR assays were developed for the differentiation of isolates into serotypes 
and detection of multiple VAGs (Silva et al., 2006; Kerdsin et al., 2014; Okura et al., 
2014). A limitation of multiplex PCR assays is the number of targets that can 
successfully be tested in a single assay (Yang and Rothman, 2004). In this study, we 
utilized pan-genome analysis in conjunction with serotyping, MLST, and VAG profiling 
as a subtyping tool for S. suis. Whole genome sequencing (WGS)-based approaches, such 
as comparative genome hybridization, minimum core genome sequence typing, pan-
genome and Bayesian analysis of population structure, and genome-wide association 
studies, have been used in combination with phenotypic methods for the identification 
and classification of S. suis strains into groups of differing levels of virulence (de Greeff 
et al., 2011; Zhang et al., 2011; Chen et al., 2013; Weinert et al., 2015; Willemse et al., 
2016; Wileman et al., 2019). WGS-based approaches have multiple advantages to 
molecular subtyping techniques, such as the ability to characterize the entire genome, a 
higher discriminatory power capable of discriminating closely related strains, the ability 
to perform in silico (via computer simulation) analyses, and access to a vast number of 
bioinformatics tools for the analysis of whole genomes (Quainoo et al., 2017; Uelze et al., 
2020). 
Novel published VAGs for the identification of pathogenic S. suis isolates were 
selected using a chi-square test and a LASSO regression model testing associations 
between published VAGs and pathotype. As a result, the two genes ofs and srtF were 
selected as the ‘best’ indicators of pathogenicity for isolates in our study. The ofs gene 
encodes a serum opacity factor and was associated with virulence attenuation in an 
experimental pig model (Baums et al., 2006). The srtF gene encodes a class C sortase and 
is part of the srtF pilus gene cluster composed of four genes, srtF, sipF, sfp1, and sfp2 
(Fittipaldi et al., 2010). SrtF gene mutants of S. suis serotype 2 ST1 strain P1/7 caused 
attenuation of virulence in an intranasal caesarean-derived colostrum-deprived (CDCD) 
pig model (Faulds-Pain et al., 2019). However, the presence of the pilus gene cluster does 
not guarantee pilus protein expression (Fittipaldi et al., 2011). Our research identifies the 
genes as markers for pathogenicity and not the expression of proteins. The percentage of 
isolates containing the ofs+/ srtF+ genotype that were classified as pathogenic increased 
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from 79 to 96% (132/137) when excluding the possibly opportunistic pathotype (isolates 
possibly associated with respiratory disease) from the analysis. The proposed pathogenic 
genotype for predicting pathogenicity was further tested in a validation set consisting of 
32 S. suis isolates to evaluate the likelihood of these two genes identifying pathogenic 
strains in other swine production companies. The ofs+/srtF+ genotype was observed in 
73.7% (14/19) of the ‘pathogenic’ isolates, together indicating a ≥ 74% probability that 
an isolate will be classified as pathogenic given the proposed genotype. The proposed 
ofs+/srtF+ genotype, in complement to the classical VAGs for ST1, identifies pathogenic 
strains in the United States. A potential application of this research is the development of 
a diagnostic PCR test targeting these two proposed VAGs. 
Nineteen of 139 isolates in the pathogenic pathotype lacked the ofs+/srtF+ 
genotype suggesting the possibility of misclassification of these isolates based on tissue 
source (systemic versus non-systemic). In addition to pathogen-specific traits, 
environmental and management conditions and host traits contribute to the development 
of S. suis disease. These factors include temperature fluctuations, overcrowding, 
concurrent infections, and host immunity and genetics (Dee et al., 1993; Reams et al., 
1994; Segura et al., 2016). The ofs+/srtF+ genotype was identified in five isolates in the 
commensal pathotype but four of these isolates were characterized as CC1 or CC94, 
which are generally pathogenic subtypes (Kerdsin et al., 2018; Hatrongjit et al., 2020). 
The five commensal isolates are present in Cluster I (Fig. 3.1), which represents a cluster 
containing all three pathotypes, indicating these isolates share similar VAGs with 
pathogenic isolates. Virulent strains have been previously isolated from the nasal cavities 
and tonsils of clinically healthy pigs, so characterization by tissue source can be 
misleading (Brisebois et al., 1990; Marois et al., 2007). 
Pan-genome analysis in combination with metadata (serotype, ST/CC, VA 
genotype) was used in this study as a subtyping tool to describe the genetic diversity of S. 
suis isolates within a production company and between companies for epidemiological 
purposes. The differentiation of S. suis may provide information on the origin of isolates 
(geographical location, year, source, etc.) or aid in the identification and tracking of 
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strains over time (Beaudoin et al., 1992; Doto et al., 2016; Dutkiewicz et al., 2017). 
Isolates from the pathogenic pathotype in this study formed distinct clusters with 
correlation to CC and VA genotypes, which is consistent with previous studies (Maneerat 
et al., 2013; Dong et al., 2017). The same CC-VA genotype patterns were identified in 
multiple production companies, suggesting a lack of association between production 
company, CC, or VA genotype. These observed patterns may be widespread as opposed 
to originating from a common source of infection as previously suggested (Mwaniki et 
al., 1994; Morales et al., 2015; Denich et al., 2020). Furthermore, the high genetic 
similarity and identical CC and VAG genotypes within a pan-genome cluster (such as in 
cluster A in production company E) are indicative of a clone, providing useful 
information for the identification and tracking of clones over time (Allgaier et al., 2001; 
van Belkum et al., 2007; Du et al., 2017). Thus, the use of WGS to complement metadata 
(e.g. epidemiological, clinical and demographical data) provides a valuable tool for 
subtyping S. suis as part of epidemiological studies (Rantsiou et al., 2018; Van Goethem 
et al., 2019). Further, pan-genome analysis of U.S. S. suis isolates may be used to identify 
candidate VAGs not yet identified or characterized. 
The differentiation of S. suis isolates is also crucial for the development of 
autogenous vaccines (Rieckmann et al., 2020). Different strains have been recovered 
from diseased pigs from the same herd and selecting the strain or strains associated with 
disease is challenging (Mogollon et al., 1991; Reams et al., 1996; Martinez et al., 2002; 
Vela et al., 2003). For the validation set, multiple CC-VA genotype patterns were found 
among the ‘pathogenic’ clusters, indicating multiple clones were present in this 
production company. This diversity of isolates is supported by the identification of five 
serotypes (1, 1/2, 2, 14, and 7) in the validation set, all of which are generally pathogenic 
subtypes (Boetner et al., 1987; Smith et al., 1999; Segura et al., 2020). Despite the 
diversity of clinical strains in the same herd, previous reports indicate a specific strain is 
the predominant cause of disease and the primary candidate for an autogenous vaccine 
(Mogollon et al., 1991; Reams et al., 1996; Torremorell and Pijoan, 1998; Martinez et al., 
2002). CC1 was predominantly identified in this production company, and these 
CC1/ST1 isolates (cluster e and f) demonstrated similar gene content (99% similarity) 
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and genotypes but had different serotypes (serotypes 1/14 vs serotype 2). These results 
suggest two sub-populations with differences in virulence potential and the need for 
multiple isolates in a vaccine (Haesebrouck et al., 2004; Hopkins et al., 2019). On the 
other hand, the CC28 isolates (cluster d) demonstrated similar gene content (92–99% 
similarity), serotypes, and genotypes, suggesting similar virulence potential, and the 
selection of a single isolate for vaccine (Fittipaldi et al., 2011; Athey et al., 2015). As 
these isolates came from the same production company, all three isolates may by 
recommended for vaccine development. In addition to the genetic diversity of S. suis 
isolates, historical background of a production company should be considered while 
selecting isolates. Historical factors such as prior on-farm identification of S. suis, 
historic and current sources of replacement animals, and other confounding disease 
factors can further support the inclusion of multiple isolates in vaccine development. 
In this study, the current distribution of published, including classical, VAGs in 
U.S. isolates was determined, which indicated that classical VAGs are not sufficient to 
differentiate pathogenic and commensal U.S. strains. Of the 71 published VAGs 
investigated, the ofs and srtF genes were shown to be stronger predictors of pathogenicity 
in both a training and a validation set of isolates. Furthermore, a WGS-based approach 
was used to determine the genetic diversity of isolates demonstrating its use in 
epidemiological studies and vaccine isolate selection. 
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Figure 3.1 Virulence-associated gene (VAG) profiling of 208 S. suis isolates. Heatmap 
illustrating the presence and absence of 71 previously published VAGs in 208 isolates. 
Isolates are annotated (right) by pathotype (pathogenic, possibly opportunistic, 
commensal). Clustering of the 208 S. suis isolates by VAGs illustrated three clusters 
(Clusters I-III), two of which (Clusters II and III) suggest associations between VAGs 
and pathotype. Serotype and clonal complex (CC) distributions in each of the three clades 





Figure 3.2 Relatedness of 208 S. suis isolates by pan-genome analysis. Genetic 
relationships between isolates are based on the presence and absence of 8373 gene 
clusters among 208 S. suis genomes. The phylogenetic tree is colored-coded (branches) 
and labeled (right) by CC; multiple STs did not form a CC or formed a CC without a 
primary founder. Isolates from at least sixteen swine production companies (A-P) (≥ 2 
isolates each) were identified in the data set. Misc. refers to miscellaneous production 
companies (single isolates each). Isolates belonging to the five predominant production 
companies (A, D, E, K, and M) are color-coded by their respective production company. 





Figure 3.3 Pan-genome analysis of isolates from the five predominant production 
companies. The predominant production companies are presented as A, D, E, K, and M. 
Color-coding of isolate names by production company and color-coding of phylogenetic 
tree branches by CC follow the same color schemes as Figure 3.2. The percent similarity 
of isolates within a cluster is defined as the percentage of shared genes from a total of 
8373 genes. The presence of the classical VAGs epf, mrp, and sly is represented in green 





Figure 3.4 Pan-genome analysis of the 22 commensal isolates. Color-coding of 
phylogenetic tree branches by CC follows the same color scheme as Figure 3.2. The 
presence of the classical VAGs epf, mrp, and sly is represented in green and the proposed 










Figure 3.5 Pan-genome analysis of the validation set of 32 S. suis isolates. Isolates are 
color coded by classification, ‘pathogenic’ (red) or ‘unknown- pathogenicity’ (blue). The 
phylogenetic tree branches are colored-coded by CC. The percent similarity of isolates 
within a cluster is defined as the percentage of shared genes from a total of 7078 genes. 
The presence of the classical VAGs epf, mrp, and sly is represented in green and the 









Table 3.1 Classical VAGs identified in the pathogenic pathotype of S. suis isolates (n = 
139) 
Subtypes   Percentage of positive 
   epf 
(n = 20, 
14.4%) 
mrp 
(n = 127, 
91.4%) 
sly 
(n = 77, 
55.4%) 
Serotypes  1 (n = 11) 35.0 5.5 14.3 
  1/2 (n = 54) 5.0 35.4 3.9 
  2 (n = 17) 30.0 11.0 7.8 
  3 (n = 18) 0.0 7.9 10.4 
  4 (n = 8) 0.0 3.1 5.2 
  5 (n = 13) 0.0 6.3 10.4 
  6 (n = 2) 0.0 0.0 0.0 
  7 (n = 23) 5.0 13.4 20.8 
  8 (n = 8) 0.0 3.1 5.2 
  9 (n = 8) 0.0 1.6 2.6 
  10 (n = 3) 0.0 0.0 0.0 
  14 (n = 5) 25.0 3.9 6.5 
  23 (n = 10) 0.0 6.3 10.4 
  24 (n = 1) 0.0 0.8 1.3 
  1or14a (n = 1) 0.0 0.0 1.3 
  NT (n = 11) 0.0 1.6 0.0 
Multilocus 
Sequence Type 
CC1b ST1 (n = 17) 85.0 13.4 22.1 
 CC1 ST87 (n = 9) 0.0 3.1 5.2 
 CC28 ST25 (n = 2) 0.0 1.6 0.0 
 CC28 ST28 (n = 52) 10.0 33.1 3.9 
 CC28 ST29 (n = 2) 0.0 1.6 0.0 
 CC28 ST117 (n = 2) 0.0 1.6 0.0 
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 CC28 ST961 (n = 10) 0.0 7.1 1.3 
 CC28 ST973 (n = 1) 0.0 0.8 0.0 
 CC94 ST94 (n = 18) 0.0 11.0 18.2 
 CC94 ST108 (n = 17) 0.0 11.0 18.2 
 CC94 ST119 (n = 2) 0.0 0.8 1.3 
 CC94 ST373 (n = 5) 0.0 3.1 5.2 
 CC94 ST839 (n = 1) 0.0 0.8 1.3 
 CC94 ST964 (n = 1) 0.0 0.8 1.3 
 CC94 ST977 (n = 9) 0.0 5.5 9.1 
 CC94 ST981 (n = 1) 0.0 0.8 1.3 
 CC104 ST225 (n = 3) 5.0 0.8 3.9 
  ST13 (n = 5) 0.0 0.0 6.5 
  ST949 (n = 1) 0.0 0.0 0.0 
  ST965 (n = 1) 0.0 0.0 0.0 
  ST967 (n = 1) 0.0 0.0 0.0 
  ST976 (n = 1) 0.0 0.0 0.0 
  ST979 (n = 1) 0.0 0.8 1.3 
  ST995 (n = 1) 0.0 0.0 0.0 
  NF (n = 4) 0.0 2.4 0.0 
a Could not differentiate serotypes 1 and 14 by coagglutination, PCR, and WGS 
b Clonal complexes (CCs) determined in our previous study (Estrada et al., 2019) 
NT = Unresolved serotype by coagglutination, PCR, and WGS 




Table 3.2 Classical VAGs epf, mrp, and sly genotypes identified in the pathotypes of S. suis isolates (n = 208) 
Virulence-
associated gene or 
genotype 
No. possessing gene  
or genotype (%) 
Pathogenic  
(n = 139) 
Possibly 
Opportunistic  
(n = 47) 
Commensal  
(n = 22) 
ST1  
(n = 17) 
ST25  
(n = 2) 
ST28  
(n = 52) 
epf 21 (10.1%) 20 1 0    
mrp 165 (79.3%) 127 32 6    
sly 99 (47.6%) 77 18 4    
epf−/mrp+/sly- 73 (35.1%) 57 14 2 0 2 49 
epf−/mrp+/sly+ 71 (34.1%) 50 17 4 0 0 1 
epf−/mrp−/sly- 36 (17.3%) 5 15 16 0 0 0 
epf+/mrp+/sly+ 21 (10.1%) 20 1 0 17 0 2 
epf−/mrp−/sly+ 7 (3.4%) 7 0 0 0 0 0 
epf+/mrp+/sly- 0 0 0 0 0 0 0 
epf+/mrp−/sly+ 0 0 0 0 0 0 0 





Table 3.3 Distribution of 71 VAGs for the pathotypes of S. suis isolates (n = 208) 
VAG No. containing 
the VAG 
Pathogenic  
(n = 139) 
Possibly 
Opportunistic  
(n = 47) 
Commensal 
(n = 22) 
adcRa 208 139 47 22 
amylopullulanasea 208 139 47 22 
ccpAa 208 139 47 22 
cdda 208 139 47 22 
ciaHa 208 139 47 22 
dpra 208 139 47 22 
enoa 208 139 47 22 
fbpSa 208 139 47 22 
feoBa 208 139 47 22 
gdha 208 139 47 22 
glnHa 208 139 47 22 
gnda 208 139 47 22 
gpmAa 208 139 47 22 
guaAa 208 139 47 22 
guaBa 208 139 47 22 
htpSa 208 139 47 22 
lgta 208 139 47 22 
lppa 208 139 47 22 
orf207a 208 139 47 22 
pepXPa 208 139 47 22 
permeasea 208 139 47 22 
pgdAa 208 139 47 22 
plr-gapAa 208 139 47 22 
purAa 208 139 47 22 
purDa 208 139 47 22 
scrBa 208 139 47 22 
scrRa 208 139 47 22 
sodAa 208 139 47 22 
srtAa 208 139 47 22 
sspAa 208 139 47 22 
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troAa 208 139 47 22 
vicR-covRa 208 139 47 22 
arcA 207 139 46 22 
ciaR 207 139 46 22 
lmb 207 139 46 22 
luxS 207 139 46 22 
phospholipaseC 207 139 46 22 
treR 207 139 46 22 
ssnA 206 139 45 22 
lspA 196 139 44 13 
manN 196 139 43 14 
zmpC 193 139 42 12 
fur 190 136 41 13 
gtfA 204 135 47 22 
dltAb 186 135 39 12 
ofsb 176 135 34 7 
sao 189 134 39 16 
GBSSAG0907-
homologueb 
175 133 35 7 
srtFb 168 132 31 5 
srtF-sipFb 167 131 31 5 
mrpb 165 127 32 6 
srtF-sfp1b 155 120 31 4 
hylAb 145 112 28 5 
virAb 142 105 26 11 
traGb 158 100 39 19 
glnAb 138 83 34 21 
endoDb 116 80 26 10 
SMU61-
homologueb 
107 78 22 7 
slyb 99 77 18 4 
neuBbc 90 77 13 0 
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srtF-sfp2b 90 77 12 1 
srtG 76 61 14 1 
srtG-sgp2 76 61 14 1 
srtG-sgp1 75 60 14 1 
adhesinP 43 30 10 3 
nadRc 25 25 0 0 
rgg 33 21 7 5 
revS 40 20 9 11 
epf c 21 20 1 0 
salKc 0 0 0 0 
salRc 0 0 0 0 
a Represents VAGs identified in all the isolates 
b Represents VAGs tested by chi-square 




Table 3.4 LASSO results for the four candidate VAGs in the pathotypes of S. suis 
isolates (n = 208) 







(n = 139) 
 Possibly  
Opportunistic  
(n = 47) 
 Commensal  
(n = 22) 
No. Proportiona  No. Proportiona  No. Proportiona 
ofs 176 135 0.767  34 0.193  7 0.040 
srtF 168 132 0.786  31 0.185  5 0.030 
neuB 90 77 0.856  13 0.144  0 0.000 
srtF-sfp2 90 77 0.856  12 0.133  1 0.011 
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Streptococcus suis is a significant economic and welfare concern in the swine industry. 
Classical molecular microbiology techniques have been utilized to traditionally 
characterize S. suis strains. Pan-genome analysis provides an in-silico approach for the 
discovery of genes involved in pathogenesis in bacterial pathogens. In this study, we 
performed pan-genome analysis of 208 S. suis isolates classified into the pathogenic, 
possibly opportunistic, and commensal pathotypes to identify novel candidate virulence-
associated genes (VAGs) of S. suis. Using the chi-square test and LASSO regression 
model, three accessory pan-genes corresponding to S. suis strain P1/7 markers 
SSU_RS09155, SSU_RS09525, and SSU_RS03100 (> 95% identity) were identified as 
having a significant association with the pathogenic pathotype. The proposed novel 
SSU_RS09155+/SSU_RS09525+/SSU_RS03100+ genotype identified 96% of the 
pathogenic pathotype suggesting a novel genotyping scheme for predicting the 
pathogenicity of S. suis isolates in the United States. In addition, mobile genetic elements 
carrying antimicrobial resistance genes (ARGs) and VAGs were identified but did not 
appear to play a major role in the spread of ARGs and VAGs. 
Impact statement The use of whole genome sequencing along with clinical metadata for 
the investigation of S. suis disease have revealed important aspects of the diversity and 
pathogenesis of this species. For example, whole genome sequencing-based approaches 
have been instrumental in determining the genomic characteristics of virulent European 
and Asian strains and the development of pathotyping tools. However, there is limited 
information on genomic characterization of U.S. isolates, and it is unclear whether the 
findings from Europe or Asia can be extrapolated to North American swine herds. In this 
study, we investigated the pan-genome, novel candidate virulence-associated genes, 
antimicrobial resistance genes (ARGs), and mobile genetic elements (MGEs) of a large 
collection of U.S. isolates. We demonstrated that isolates belonging to the three 
pathotypes share ARGs, MGE-linked genes, and various other genes, and can be 
differentiated by the presence of three novel pan-genome based markers. The findings of 
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this work may emphasize the advantages of whole genome sequencing of U.S. S. suis 
isolates and the need for contemporary comparative studies.  
Keywords Streptococcus suis, virulence-associated genes (VAGs), pathotype, 
comparative genomics 
4.2 Introduction 
Streptococcus suis is a significant economic and welfare concern in the swine 
industry as pathogenic strains cause a range of clinical signs including meningitis, 
arthritis, endocarditis, and septicemia (Gottschalk and Segura, 2019). Commensal strains 
naturally colonize the upper respiratory tract of pigs without causing clinical disease 
(Arends et al., 1984). Characterization techniques capable of identifying strains of 
clinical significance are important for the control of S. suis disease. Virulence-associated 
factors contributing to the virulence of S. suis strains (mainly for serotype 2) have been 
described but are not consistently present in clinical isolates (Fittipaldi et al., 2012; 
Segura et al., 2017). S. suis virulence-associated factors remain unknown or are 
geographically specific. 
Increasing availability of next generation sequencing technologies and generation 
of large amounts of data led to the development of numerous programs and software tools 
for bacterial typing (Carriço et al., 2013; Edwards and Holt, 2013). Pan-genome analysis 
characterizes the diversity within a bacterial species as it describes core traits shared by 
all strains and unique/accessory traits shared only by some strains (Medini et al., 2005). 
S. suis possesses an open pan-genome in which the number of unique or accessory genes 
increases as more genomes are sequenced (Zhang et al., 2011). The open pan-genome 
contributes to high species diversity and is typically indicative of high rates of horizontal 
gene transfer by mobile genetic elements (MGEs) (Medini et al., 2005; Rouli et al., 
2015). Functional analyses of the S. suis pan-genome revealed differences in the 
functional annotation of the core genome compared to the accessory genome (Zhang et 
al., 2011; Guo et al., 2020), supporting the distinct roles of these two components in 
explaining genomic diversity. Comparative genomics can also be used as a subtyping tool 
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for S. suis. Serotype 1, 2, 7, and 9 strains were differentiated by comparative genome 
hybridization or bayesian analysis of population structure analysis into multiple genomic 
groups, some of which correlated to virulence and traditional molecular subtyping 
techniques (de Greeff et al., 2011; Willemse et al., 2016). 
The ability to identify virulence determinants within the accessory genome has 
been demonstrated for various bacterial pathogens such as Escherichia coli, 
Pseudomonas aeruginosa, and Streptococcus spp. (Rasko et al., 2008; Kilian and 
Tettelin, 2019; Allen et al., 2020). Known and putative VAGs were over-represented in 
systemic isolates of S. suis compared to respiratory and non-clinical isolates (Weinert et 
al., 2015). In a separate study, a genome-wide association study was utilized to identify 
three novel genetic markers for differentiating S. suis isolates into invasive disease-
associated and non-disease-associated groups (Wileman et al., 2019). That pathotyping 
tool, which consisted of a multiplex-PCR assay, demonstrated performance metrics (e.g., 
sensitivity, specificity) similar to serotyping, multilocus sequence typing (MLST), VAG 
profiling, and minimum core genome sequence typing. Two recent publications on the 
comparative analysis of virulent and avirulent strains identified two different sets of 
novel virulence-associated genes, supporting previous claims of an abundance of 
uncharacterized virulence determinants in the accessory genome of pathogenic strains 
(Guo et al., 2020; Nicholson et al., 2020).  
Mobile genetic elements facilitate intracellular and intercellular movement of 
genes and contribute to the evolution of pathogenic bacteria such as S. suis (Frost et al., 
2005; Huang et al., 2016; Partridge et al., 2018). MGEs are a large group of DNA 
fragments that include plasmids, integrative conjugative elements (ICE), integrative 
mobilizable elements (IME), composite transposons, and pathogenicity islands (PAI), 
some of which are mobile by conjugation. Proteins encoded by MGEs have various 
functions that can be described as core traits required for replication and 
advantageous/adaptive traits (e.g., antimicrobial resistance genes (ARGs), virulence-
associated genes (VAGs)) (Frost et al., 2005; Rankin et al., 2011). Previous studies 
demonstrated the transfer of conjugative ICESsu32457 to S. agalactiae, S. pneumoniae, 
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and S. pyogenes, indicating the dissemination of resistance genes among closely related 
species (Palmieri et al., 2012; Marini et al., 2015). Virulence-associated factors 
associated with mobile genetic elements have been identified in E. coli, Legionella 
pneumophila, P. aeruginosa and S. suis (Rasko et al., 2008; D’Auria et al., 2010; Zheng 
et al., 2011; Allen et al., 2020). An 89kb PAI was first identified in the highly virulent 
and zoonotic Chinese S. suis strain 05ZYH33, and it contains both resistance genes and 
putative VAGs (Chen et al., 2007; Li et al., 2008). There is evidence that S. suis serves as 
an MGE reservoir for other streptococci, and there are many poorly characterized MGEs 
yet to be discovered (Huang et al., 2016; Hadjirin et al., 2020). 
Comparative genomics provides a powerful tool for the characterization and 
subtyping of S. suis. However, a contemporary comparative pan-genomic study targeting 
U.S. S. suis strains is still incomplete. We performed comparative genome analysis on a 
set of 208 S. suis isolates from North America (mainly the United States) to identify 
accessory genes corresponding to the pathogenic pathotype and thus may serve as novel 
candidate virulence-associated genes of S. suis. The identification of candidate VAGs 
may elucidate a novel VAG genotyping scheme for predicting the pathogenicity of S. suis 
isolates in the United States. Further, we determined the diversity of MGEs in U.S. S. suis 
isolates and investigated their role in the dissemination of ARGs and VAGs among S. 
suis pathotypes. 
4.3 Materials and methods 
4.3.1 Sample selection and genome assembly 
The study utilized all 208 S. suis genomes (referred to as the training set) 
previously described by Estrada et al. (Estrada et al., 2019). These isolates were 
previously classified into pathotypes and characterized by serotyping, MLST, and VAG 
profiling. Briefly the three pathotypes are pathogenic (systemic tissues), possibly 
opportunistic (lung tissues), and commensal (laryngeal, tonsil, or nasal samples). Genome 
assembly was performed on Illumina sequencing data of the 208 S. suis isolates SRA 
accession numbers SRR9123061-SRR9123268. Genome assemblies (contigs) were 
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generated using the SKESA de-novo assembler (v2.4.0) (Souvorov et al., 2018) with 
default kmer settings. QUAST (v4.5) (Gurevich et al., 2013) was used to evaluate the 
genome assemblies and generate summary statistics (e.g. genome length, GC content, 
N50) for contigs ≥ 500 bp. Only contigs ≥ 500 bp were kept for annotation by Prokka 
(v1.14.6) (Seemann, 2014) to predict coding sequences. The pan-genome was annotated 
using Roary (v3.13.0) (Page et al., 2015) using a 90% BLASTp identity cut-off to define 
clusters of genes and allowing paralog clustering. Gene clusters present in 99% (≥ 
206/208) of genomes were classified as core genes. Two different Roary analyses were 
performed. The first analysis utilized all 208 genomes while the second analysis utilized 
the 161 genomes representing only the pathogenic and commensal pathotypes.  
4.3.2 Functional annotation 
The Clusters of Orthologous Groups of proteins (COG) database (2014) (Galperin 
et al., 2015) was utilized to predict protein functions. For each gene cluster identified by 
Roary, a representative protein sequence was selected, and BLASTp searches against the 
COG database were performed. COG functional classes from searches meeting the 
thresholds (coverage ≥ 70%, identity ≥ 70%, and e-value ≤ 10-5) were plotted using R 
software (v3.6.1) (R Core Team, 2017). 
4.3.3 Statistical analysis 
Basic data transformation and statistical analyses were performed using R 
software. Associations between S. suis accessory genes and pathotype were investigated. 
The data were filtered by removing genes detected in less than 50% (≤ 69/139) of isolates 
within the pathogenic pathotype and detected in more than 50% (≥ 11/22) of isolates 
within the commensal pathotype. Remaining accessory genes were individually tested by 
chi-square using a 3x2 table comparing the three pathotypes and the status 
(presence/absence) of individual genes. Genes lacking a significant (p-value < 0.05) 
association with pathotype were removed from the analysis. The remaining genes were 




4.3.4 LASSO shrinkage regression model 
A LASSO shrinkage regression model was used, as previously described by 
Estrada et al (Estrada et al., 2021), to determine the fewest number of accessory genes 
that may serve as predictors of pathogenicity; the pathogenic pathotype served as the 
indicator of pathogenicity. The LASSO analysis (100 iterations) was performed on each 
Roary data set, the first data set consisting of all 208 isolates, and the second consisting 
of a subset of 161 isolates (Figure 1). Genes identified in both LASSO analyses were 
selected as the 'best' predictors of pathogenicity. 
4.3.5 Identification of antimicrobial resistance genes 
The presence of antimicrobial resistance genes (ARGs) was predicted in all 208 S. 
suis draft genomes (contigs) using the Comprehensive Antibiotic Resistance Database 
(CARD) (v3.1.0) and the CARD BLAST command-line program (Alcock et al., 2020) 
(BLASTn, ≥ 90% identity and ≥ 60% coverage). 
4.3.6 Identification of mobile genetic elements 
Plasmids and other genetic elements (insertion sequences, ICE, IME, composite 
transposons, etc.) were identified in the S. suis draft genomes using the command-line 
PlasmidFinder (Carattoli et al., 2014) and MobileElementFinder (Johansson et al., 2021) 
programs (default parameters: ≥ 90% identity and ≥ 60% coverage). The PlasmidFinder 
database, which is a curated database of plasmid replicons, was updated to include S. suis 
plasmid replicons (pNSUI060a: CP012912, pNSUI060b: CP012913, HN105 unnamed 
plasmid1: CP029399, pSRD478: CP017089, pISU2812: CP017093, pISU2514: 
CP030021, pISU2614: CP031378, pYSJ17: CP032065). The MobileElementFinder 
database contains genetic elements from several public databases including RefSeq, Tn 
registry and ICEberg. The presence of the S. suis strain 05ZYH33 89K candidate 
pathogenicity island (PAI) was determined in-silico by screening for the CH1/CH2, 
CH3/CH4 and CH5/CH6 DNA sequences (Chen et al., 2007; Schmid et al., 2011) using 
the SRST2 (Short Read Sequence Typing for Bacterial Pathogens) program (≥ 90% 
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coverage and ≥ 90% sequence identity) (Inouye et al., 2014). The CH3 and CH4 
sequence is a 716bp fragment unique to the strain 05ZYH33 89K PAI, thus isolates 
lacking this segment were considered negative for the PAI. PAI draft sequences were 
extracted from the genomes by mapping the trimmed reads to the S. suis strain 05ZYH33 
89K PAI (Yoon et al., 2015). The plasmid, ICE, IME, composite transposon, and 89K 
PAI draft sequences were annotated using Prokka. Associations between the presence of 
MGEs and pathotype were tested by chi-square. 
4.3.7 Identification of MGE-associated ARGs and VAGs  
Comparative analysis to identify genetic elements carrying ARGs and putative 
VAGs was performed by BLAST searching MGE draft sequences against a custom 
database [BLASTn (dc-megablast), ≥ 80% identity and ≥ 60% coverage]. The CARD 
(v3.1.0), CGE ResFinder (02-19-2021), and ARG-ANNOT ARG (v6) databases, and the 
VF (03-01-2021), CGE VirulenceFinder (05-29-2020), and S. suis VAG databases were 
combined into one custom ARG-VAG BLAST database. Potential ARGs and VAGs 
were also determined from prokka annotations. 
4.4 Results 
Identification of core and accessory gene content 
In the current study, the pan-genome (core and accessory genes) of the training set 
was determined. The genome lengths ranged from 1.95-2.45 Mb with an average 
coverage of 65-324x across the assembly and an average GC content of 40.8-41.6% 
(Appendix 4.1). The number of predicted protein coding sequences ranged from 1,854 to 
2,399, with an average of 2,078. A total of 8,231 gene clusters were identified 
(Additional file 4.1). Of these, 1,189 gene clusters were classified as core genes and were 
present in all or nearly all genomes (≥ 206/208). A decrease in the number of conserved 
or core genes was observed as more genomes were added to the analysis (Figure 4.2A) 
while an increase in the number of unique genes was observed (Figure 4.2B). 
Furthermore, the total number of genes in the pan-genome continued to increase with 
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each additional genome (Figure 4.2C), suggesting an open pan-genome for S. suis and 
indicating a potential to discover novel genes with the sequencing of more S. suis strains. 
These genome lengths, CG content, and number of predicted proteins sequences are 
consistent with the S. suis reference strains already in the GenBank/EMBL/DDBJ 
database. 
Cluster of Orthologous Groups classification 
The COG functional classes were predicted for 98.7% (8123/8231) of gene 
clusters identified in the pan-genome of S. suis. The comparison of COG functional 
classes between core and accessory genes was performed only on the 995 classifications 
that met the criteria (coverage ≥ 70%, percent identity ≥ 70%, and e-value ≤ 10-5) 
(Figure 4.3A, Additional file 4.2). Core genes were more likely to be classified into 
functional classes T (signal transduction mechanisms), J (translation, ribosomal structure 
and biogenesis), F (Nucleotide transport and metabolism), and O (Posttranslational 
modification, protein turnover, chaperones), in decreasing order. More accessory genes 
were classified into classes X (Mobilome: prophages, transposons) and V (Defense 
mechanisms), in decreasing order (Figure 4.3B). Major differences were lacking in the 
distribution of COG classes by pathotype (Figure 4.3C). 
Candidate VAGs 
Statistical analyses were performed to test for associations between accessory 
genes and the three pathotypes. Of the 7,042-accessory pan-genes identified for the 
training set, 231 pan-genes met the criteria (p-value < 0.05, <50% commensal, >50% 
pathogenic, Figure 4.1A) to be further analyzed by the LASSO model. Similar analysis 
was performed on the commensal and pathogenic pathotypes only (n=161) (Additional 
file 4.3), and 223 pan-genes were associated with the pathogenic pathotype and further 
analyzed by the LASSO model (Figure 4.1B). Four genes corresponding to S. suis strain 
P1/7 markers SSU_RS09155, SSU_RS01590, SSU_RS09525, and SSU_RS03100 (> 95% 
identity) were identified in both LASSO analyses (Table 4.1) and were further 
investigated as novel predictors of pathotype. The 
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SSU_RS09155+/SSU_RS09525+/SSU_RS03100+ genotype was observed in 96.4% 
(134/139) and 13.6% (3/22) of the pathogenic and commensal pathotypes, respectively 
(Table 4.2). Genotypes containing marker SSU_RS01590 identified fewer pathogenic 
isolates. Thus, only markers SSU_RS09155, SSU_RS09525, and SSU_RS03100 were 
selected as the ‘best’ predictors of pathotype. We further investigated these markers in 
eight virulent Eurasian reference strains by BLASTn (Table 4.3). The three markers were 
identified in all eight strains with ≥ 96% identity and 100% coverage.  
Identification of ARGs 
The presence of ARGs was predicted in all S. suis draft assemblies of the training 
set (Additional file 4.4). Fifteen ARGs representing five drug classes (aminoglycoside, 
lincosamide, macrolide, nucleoside, and tetracycline) were identified in at least one 
isolate (Figure 4.4A). The predominant ARGs were tet(O) (90.4%, 188/208) and erm(B) 
(69.7%, 145/208), which confer resistance to tetracycline and MLS 
(macrolide/lincosamide/streptogramin) antibiotics, respectively. Notably, ~77% of the 
commensal and possibly opportunistic pathotypes possessed macrolide resistance genes 
and 14.9% of the possibly opportunistic possessed aminoglycoside resistance genes 
compared to 66.2% and 2.9% of the pathogenic pathotype, respectively (Figure 4.4B). 
Multidrug resistance (ARGs conferring resistance to ≥ 3 drug classes) was determined in 
11.0% (23/208) of isolates. 
Identification of S. suis MGEs and MGE-associated ARGs and VAGs 
The presence of various MGE types was determined in-silico. Plasmid replicons 
were predicted in 58.2% (121/208) of S. suis genomes (Figure 4.5A), and 15.7% (19/121) 
of these contained multiple (2-3) plasmid replicons. Ten different plasmids were 
predicted, and the predominant plasmid types were the S. suis plasmids pNSUI060a 
(54.3%, 113/208), pISU2614 (6.7%, 14/208), and pSSU1 (AB019522) (6.7%, 14/208) 
(Additional file 4.4). There was no association (p-value > 0.05) between the presence of 
plasmids and pathotype; however, a majority (61.9%, 86/139) of the pathogenic 
pathotype contained at least one plasmid compared to a minority (40.9%, 9/22) of the 
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commensal pathotype. Insertion sequences, ICEs, IMEs, and composite transposons were 
predicted in 98.1% (204/208), 2.4% (5/208), 1.9% (4/208), and 34.6% (72/208) of 
genomes, respectively. There was a significant association (p-value < 0.05) between the 
presence of predicted composite transposons and pathotype with 40.3% (56/139) of the 
pathogenic pathotype possessing at least one composite transposon compared to 9.1% 
(2/22) of the commensal pathotype. The S. suis strain 05ZYH33 89K PAI was 
determined by the CH3/CH4 internal PAI sequence, which was lacking in all isolates of 
the training set (Figure 4.5A). The CH1/CH2 (5’ flanking region) and CH5/CH6 (3’ 
flanking region) sequences were identified in 20.2% (42/208) and 39.4% (82/208) of 
isolates, respectively. 
The ARGs and VAGs carried on the predicted MGEs were identified by a 
BLAST search of the MGE draft sequences to the custom ARG-VAG database 
(Additional file 4.4). In the training set, 5.8% (12/208) of the isolates contained ARGs 
aminoglycoside 6-adenylyltansferase (SSU05_0957) and tetracycline resistance protein 
(SSU05_0922) in the S. suis strain 05ZYH33 89K PAI (Figure 4.5B). Higher percentages 
of possibly opportunistic (12.8%, 6/47) and commensal (9.1%, 2/22) isolates carried 
ARGs compared to pathogenic isolates (2.9%, 4/139). ARGs (erm(B), lnuC, and/or 
tet(M)) were identified in plasmids, ICEs, and composite transposons of 1.4% (3/208) of 
isolates and in IMEs of 1.9% (4/208) of isolates. None of the isolates possessing these 
ARG-associated MGEs were classified as the commensal pathotype. 
Putative VAGs were identified on PAI-like sequences of 94.2% (196/208) isolates 
(Figure 4.5C). These VAGs included the S. suis strain 05ZYH33 agglutinin receptor 
(SSU05_0965) and type IV secretory system VirB4/VirD4 components 
(SSU05_0969/SSU05_0973), which were present in ≥ 75% (≥ 157/208) of genomes 
(Additional file 4.4). Other PAI-associated VAGs present in the genomes were 
NisK/NisR (SSU05_0906/SSU05_0907), putative zeta toxin (SSU05_0936), and putative 
abortive infection protein (SSU05_0966). These PAI-associated VAGs were identified in 
all three pathotypes with no major difference in distribution by pathotype. VAGs were 
identified in less than 5% (n < 10) isolates with predicted plasmids, ICEs, IMEs, and 
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transposons, and included S. suis orf207, revS, and traG. The proposed novel VAGs 
SSU_RS09155, SSU_RS09525, and SSU_RS03100 were not associated with MGEs 
predicted in this study, as determined by BLAST. In summary, ARGs and VAGs were 
identified in multiple MGE types and PAI-like regions were the most diverse. 
4.5 Discussion 
In this study, comparative analysis of 208 previously characterized S. suis isolates 
(Estrada et al., 2019) was performed to gain insights into the distribution and function of 
the S. suis core and accessory genomes. Functional comparisons illustrated differences in 
COG classes with the potential enrichment of virulence-associated genes in the accessory 
genome. Markers SSU_RS09155, SSU_RS09525, and SSU_RS03100 demonstrated strong 
associations with the pathogenic pathotype presenting a novel candidate VAGs for 
identifying pathogenic S. suis strains in the United States. We investigated the 
distribution of MGEs and determined that MGEs have the potential to spread resistance 
genes and putative VAGs. 
Functional annotation of the pan-genome was performed using the COG protein 
database to investigate differences in the abundance of classes between core and 
accessory genes. Genes involved in nucleotide transport, translation, posttranslation 
modifications, and signal transduction mechanisms (COG F, J, O, and T) were over-
represented among the core genes. These functions (represented by COG F, J, O, and T) 
can more broadly be described as cellular processing and signaling, information storage, 
and metabolism and are responsible for basic cell function ('housekeeping') (Zheng et al., 
2011; Shelyakin et al., 2019). Accessory genes were more likely to be involved in 
defense mechanisms and the mobilome (COG X and V), which are functions associated 
with host- and environmental-interactions, horizontal gene transfer, and niche-adaptation 
in bacterial pathogens (Ward et al., 2009; Brambila-Tapia et al., 2014; Shelyakin et al., 
2019). Thus, the distribution and function of the S. suis pan-genome support our 




Candidate novel VAGs in the S. suis accessory genome were selected using a chi-square 
and LASSO regression models testing associations between accessory genes and 
pathotype. Three pan-genes corresponding to S. suis strain P1/7 genes SSU_RS09155, 
SSU_RS09525, and SSU_RS03100 were selected as the ‘best’ indicators of pathogenicity 
for isolates in our study. In our previous study, we demonstrated that a genotype 
consisting of classical S. suis VAGs extracellular protein factor, muramidase-released 
protein, and suilysin (epf+/mrp+/sly+) only identified 14% of the pathogenic pathotype, 
while a novel proposed genotype of published VAGs ofs and srtF (ofs+/srtF+) was able 
to identify 95% (Estrada et al., 2021). Yet, virulent strains lacking ofs and/or srtF have 
been reported in North America, indicating these VAGs are not essential for virulence 
(Fittipaldi et al., 2011, 2012). The SSU_RS09155+/SSU_RS09525+/SSU_RS03100+ 
genotype identified 96% of the pathogenic pathotype and only 14% of the commensal 
pathotype. Previous studies suggest Eurasian and North American strains are 
genotypically and phenotypically different and may possess different virulence markers 
(Fittipaldi et al., 2011; Gottschalk and Segura, 2019). While Eurasian type strains 
(serotype 2) are not predominant in the United States, these strains are still identified 
(Estrada et al., 2019). The identification of the SSU_RS09155, SSU_RS09525, and 
SSU_RS03100 markers in all eight Eurasian strains tested suggests these markers can 
potentially be applied globally. The application of these virulence markers to Eurasian 
strains needs to be verified using a large collection of isolates including non-serotype 2 
and commensal strains. 
 
Using a genomic approach, the predicted function of these candidates VAGs and 
their potential relevance to S. suis disease were investigated. SSU_RS09155 and 
SSU_RS03100 were annotated as hypothetical proteins and have been reported in virulent 
S. suis strains such as P1/7, SC84, and GZ1. Markers SSU_RS09155 and SSU_RS03100 
could not be further characterized by COG or by searching the NCBI protein databases, 
reinforcing that much of the S. suis genome is uncharacterized or poorly characterized. 
SSU_RS09525 was annotated as an RNA-binding protein (RBP), which are involved in 
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post-transcriptional regulation via regulation of translation initiation, stability, and 
transcript elongation (Van Assche et al., 2015; Oliveira et al., 2017). RBPs are well-
studied in E. coli and Salmonella enterica serovar Typhimurium and were shown to 
affect virulence gene expression (Liu and Romeo, 1997; Westermann et al., 2019). 
SSU_RS01590 encodes a putative energy-coupling factor transporter substrate-binding 
protein (ECF transporter S component). ECF transporters are responsible for vitamin 
uptake and are essential for growth and survival, contributing to the virulence of various 
gram-positive bacterial pathogens (Eitinger et al., 2011; Bousis et al., 2019). The strong 
associations with the pathogenic pathotype and potential virulence-related functions 
suggest the proposed markers contribute to the pathogenicity of S. suis. 
Fifteen ARGs conferring resistance to aminoglycoside, lincosamide, macrolide, 
nucleoside, and tetracycline antibiotics were identified in the draft genomes of the 
training set. High resistance to tetracyclines (93%, predominantly tet(O)) and 
erythromycin (70%, erm(B)) was observed similar to previous reports of resistance in S. 
suis in North America, Asia, and Europe (Varela et al., 2013; Seitz et al., 2016). Previous 
studies indicate a higher prevalence of antibiotic resistance among commensal strains, 
which may act as reservoirs for resistance genes (Hernandez-Garcia et al., 2017; 
Lugsomya et al., 2018). There was no major difference in the distribution of resistance 
genes by pathotype, but the commensal and possibly opportunistic pathotypes did tend to 
have more resistance genes.  
Horizontal gene transfer of MGEs is one mechanism by which S. suis acquires 
and spreads resistance genes and putative VAGs. Thus, a genomic approach was used for 
the in-silico prediction of MGEs in S. suis genomes and the investigation of genes carried 
on these elements. Resistance MGEs were identified in only 6% of isolates, largely 
classified as pathogenic and possibly opportunistic (83%) and were predominantly 
present in PAI-like regions. However, only a few isolates (3.4%, n=7) had multiple 
resistance MGEs. ICE and IME are commonly found in Streptococcus genomes and play 
a major role in the dissemination of ARGs in S. suis (Holden et al., 2009; Libante et al., 
2019). In our study, only the 69kb S. suis ICESsuZJ20091101-1-like ICEs (n=3) and 
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1.7kb Streptococcus agalactiae MTnSag1-like IMEs (n=4) carried resistance genes 
(erm(B), lnuC, and tet(O)). Less than 2% of isolates possessed resistance plasmids 
although this may not be uncommon as there are limited reports of S. suis plasmids 
carrying ARGs (Cantin et al., 1992; Wang et al., 2013) and resistance plasmids are 
largely found in gram-negative bacteria (Vrancianu et al., 2020). Overall, this MGE 
mechanism of antimicrobial resistance represents 77%, 2%, and 5% of the predicted 
aminoglycoside, tetracycline, and lincosamide/macrolide resistance, respectively, 
regardless of pathotype. Our findings suggest MGEs continue to play a role, although 
limited, in the spread of antimicrobial resistance. 
Putative VAGs were identified among the various MGE types, but mostly on 
PAI-like sequences, and the predominant VAGs encode an agglutinin receptor and type 
IV secretion system components (T4SS). Agglutinin receptors (adhesion proteins) and 
T4SS contribute to S. suis virulence (serotypes 9 and 2, respectively) by promoting anti-
phagocytic activity and the release of proinflammatory cytokines (Jiang et al., 2016; 
Auger et al., 2019). The agglutinin receptor was present in 86% of the commensal 
pathotype compared to 72% of the pathogenic pathotype while the T4SS components 
were widely distributed among the three pathotypes (86-96%). Our results indicated a 
lack of correlation between the presence of MGE-associated VAGs and pathotype. The 
presence of VAGs in a majority of the commensal pathotype provides further evidence 
that commensal strains may act as gene reservoirs (von Wintersdorff et al., 2016; Rossi et 
al., 2020). Although the 89K PAI (a S. suis MGE) was absent in all isolates in this study, 
the in silico detection of 89K PAI sequences (CH1/CH2 and CH5/CH6) and the presence 
of PAI VAGs suggests some genetic similarity between U.S. isolates and the virulent S. 
suis strain 05ZYH33 (Schmid et al., 2011). 
Genes involved in the maintenance of MGEs were also determined from the MGE 
drafts (as determined by BLAST and prokka annotations) (Additional file 4.5). 
Replication proteins (helicases, primases, replication initiators), integrases/recombinase, 
and transposases are important for the formation and integration of MGEs (Gérard 
Guédon et al., 2017), and were annotated in 71-98% of our isolates with the last two 
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predominantly found in the pathogenic and possibly opportunistic pathotypes. 
Transcriptional regulators play a role in the expression of genes in and surrounding 
MGEs and were present in all three pathotypes (91-100%). Toxin-antitoxin and abortive 
infection proteins are responsible for the maintenance of resistance MGEs by promoting 
degradation of bacterial cells lacking the MGEs (Díaz-Orejas et al., 2017; Yang and 
Walsh, 2017). A putative zeta/pezT toxin (SSU05_0936) was predominantly identified in 
the pathogenic and possibly opportunistic pathotypes (70-72%). Many of the MGE drafts 
in our study contained genes encoding major carbohydrate transport systems (PTS 
transporters) (28%), a mobility protein (methyl-accepting chemotaxis protein) (72%), and 
metal resistance proteins (arsenic, calcium) (76-77%). Together these findings agree with 
publications stating MGEs carry a range of genes that contribute to the survival and 
adaptation of pathogenic bacteria to dynamic environments (Rankin et al., 2011; Durrant 
et al., 2020). Our results suggest MGE-mediated transfer of beneficial genes, including 
resistance genes and VAGs, is possible in U.S. S. suis isolates. 
Comparative genome analysis of 208 S. suis isolates demonstrated a potential 
enrichment of virulence-associated genes in the accessory genome and elucidated a novel 
VAG genotyping scheme (SSU_RS09155+/SSU_RS09525+/SSU_RS03100+) for 
identifying pathogenic S. suis strains in the United States. We further determined the 
diversity of MGEs in the training set and determined that MGEs have the potential to 
gain/or spread resistance genes and putative VAGs between S. suis strains. Further 
research is needed in vitro to evaluate the contribution of the proposed VAGs to 
virulence. 
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Figure 4.1 Illustration of the pan-genome approach for identifying candidate 
virulence-associated genes (VAGs). (a) The first data set analyzed consisted of all 208 
isolates and (b) the second data set consisted of a subset of 161 isolates. Genes with a 
significant association (p-value < 0.05) with pathotype, and present in more than 50% 
(69/139) of isolates within the pathogenic pathotype and present in less than 50% (11/22) 
of isolates within the commensal pathotype, were analyzed using the LASSO shrinkage 
regression model. Genes identified in both LASSO analyses were selected as the 'best' 
predictors of pathotype.  
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Figure 4.2 Summary statistics for the pan-genome analysis of 208 S. suis isolates. (a) Number of conserved genes, (b) unique 



































































Figure 4.3 Predicted Cluster of Orthologous Groups (COG) functional classes. COG 
functional classes were determined for the 995 pan-gene clusters that met the criteria 
(psiblast, coverage ≥ 70%, percent identity ≥ 70%, and e-value ≤ 10-5). (a) The total 
frequencies of pan-gene clusters classified into each COG functional class (single-letter 
code) were plotted and color-coded. (b) The percentages of accessory and core pan-gene 
clusters classified into each COG functional class were plotted. (c) The percentages of 
pan-gene clusters (from each COG class) present in each pathotype (pathogenic, possibly 





Figure 4.4 Antimicrobial resistance genes (ARGs) and drug classes determined in S. 
suis isolates (n=208). (a) Percentage of isolates possessing each of the 15 ARGs 
identified, conferring resistance to aminoglycosides, lincosamides/macrolides, 
nucleosides, and tetracyclines. ARGs were subdivided by pathotype (stacked bar 
sections; pathogenic, possibly opportunistic, and commensal). (b) Percentage of each 


















































































































































Figure 4.5 Mobile genetic elements carrying ARGs and VAGs. Percentage of each 
pathotype (pathogenic, possibly opportunistic, and commensal) possessing (a) various 
MGE types, (b) ARG-associated MGEs, and (c) VAG-associated MGEs. S. suis strain 
05ZYH33 89K PAI sequences CH1/CH2 (5’ flanking region), CH3/CH4 (716bp internal 
fragment), CH5/CH6 (3’ flanking region). Total percentage and number of isolates 























































































































































































































































































86 DNA repair protein 
group_2061b group_1532 SSU0541 (P1/7) (CAR45198.1) 116 transposase 










150 hypothetical protein 
group_1993 group_2992c WP_012027348.1 76 hypothetical protein 
a Pan-genes identified in both LASSO analyses that were selected as predictors of pathogenicity 
b Candidate VAGs identified by LASSO analysis of 208 
genomes 
  
c Candidate VAGs identified by LASSO analysis of 161 genomes (only pathogenic and commensal 
pathotypes) 
* Group name is unique and determined by each ROARY analysis. Hence, group names are different 






Table 4.2 LASSO results for the four candidate VAGs in the pathotypes of S. suis 







(n = 139) 
Possibly 
Opportunistic  
(n = 47) 
Commensal  
(n = 22) 
No. Proportion* No. Proportion* No. Proportion* 
SSU_RS09155 178 137 0.770 34 0.191 7 0.039 
SSU_RS01590 167 127 0.760 31 0.186 9 0.054 
SSU_RS09525 189 138 0.730 42 0.222 9 0.048 




168 134 0.798 31 0.185 3 0.018 







Table 4.3 Presence of novel candidate VAGs in virulent Eurasian S. suis strains 











Source Origin Accession no. Ref 
GZ1 2 1 96.1 98.8 100 human China CP000837 (Ye et al., 2009)  
SC84 2 7 96.1 98.8 100 human China FM252031 (Holden et al., 2009)  
P1/7 2 1 96.1 98.8 100 diseased pig United 
Kingdom 
AM946016 (Holden et al., 2009)  
S735 2 1 96.1 98.8 100 diseased pig The 
Netherlands 
CP003736 (Boyle et al., 2012)  
ZY0571
9 
2 7 96.1 98.8 100 diseased pig China CP007497 (Zhang and Lu, 2007)  
SC19 2 7 96.1 98.8 99.7 diseased pig China CP020863 (Li et al., 2010a)  
05ZYH
33 
2 7 96.1 97.4 100 human China CP000407 (Chen et al., 2007)  
10 2 1 96.1 98.8 100 healthy pig The 
Netherlands 











This dissertation studied the epidemiology and genomic characterization of S. suis 
and various methods for differentiating pathogenic strains. This was in an effort to 
address the lack of reports on S. suis diversity and pathogenicity in the United States. Our 
approach was modeled off traditional methods utilized in Europe, Asia, and Canada for 
characterizing virulent porcine and human clinical isolates. 
In Chapter 2 we elucidated the heterogeneity of S. suis isolates originating from 
US swine herds by serotyping and MLST and defined a pathotype classification system 
for investigating links between subtypes (serotype and ST) and S. suis disease. U.S. 
isolates were highly diverse, representing 20 different serotypes and 58 different STs. 
Furthermore, subtype distributions were similar to that of Canada but differed from that 
of European and Asian countries. Investigation by pathotype classification revealed that 
only some subtypes were uniquely associated with diseased animals, supporting previous 
studies that found that despite the heterogeneity of S. suis, a small number of subtypes are 
likely responsible for a majority of clinical cases. Although unique pathogenic subtypes, 
such as SS1/2 and ST28, were prevalent in the United States, globally reported virulent 
strains, particularly SS2 and ST1, were also identified and should be monitored. In 
addition, a few subtypes were uniquely associated with healthy animals and a large 
number of novel STs were discovered in commensal and possibly opportunistic isolates, 
indicating commensal and opportunistic strains contribute to the high genetic diversity of 
S. suis. 
In Chapter 3 we evaluated the distribution of previously published S. suis VAGs 
and their associations with pathotypes, subtypes, and epidemiological origin (swine 
production companies) of the isolates. We first demonstrated that a majority of the 
pathogenic pathotype lacked the three "classical" virulence markers of SS2 Eurasian 
strains (epf, mrp, and sly) and that U.S. pathogenic strains likely possess different VAGs. 





Chapter 2, and were detected using the classical VAGs. Therefore, the epf, mrp, and sly 
genes remain valuable virulence markers for S. suis. General clustering of isolates by 
VAG profiles demonstrated that pathogenic strains possessed more VAGs than the 
commensals and that there were candidate genes capable of discriminating between 
pathotypes. We investigated candidate VAGs by statistical analyses and determined that 
the ofs and srtF genes better serve as predictors of pathogenicity than the presence of the 
classical VAGs. Thus, the incorporation of the ofs and srtF genes in diagnostic testing 
may improve the subtyping and detection of strains with increased virulence potential, 
including non-SS2 strains that are prevalent in U.S. swine herds. The comparison of S. 
suis isolates originating from different production companies depicted high diversity 
within and between production companies, and there was a lack of association between 
genotypes and production company. This suggests that strains of clinical significance 
may be widespread in the United States. 
In Chapter 4 we investigated novel candidate virulence-associated genes and 
predicted antimicrobial resistance genes and mobile genetic elements of U.S. S. suis 
isolates. Functional annotation of the pan-genome provided further evidence that the S. 
suis accessory genome possesses genes with virulence-related functions and may be 
prone to horizontal gene transfer (mobilome). We identified four accessory pan-genes 
with a strong association with the pathogenic pathotype. Three of these genes, 
corresponding to the S. suis strain P1/7 genes SSU_RS09155, SSU_RS09525, and 
SSU_RS03100, were shown to be promising novel markers for U.S. pathogenic strains 
and potentially global strains. These markers, along with the classical and newly 
proposed markers described in Chapter 2, may serve as targets for diagnostic tests. In 
general, our approach helped identify genes and their predicted encoded proteins that 
may play a role in the pathogenesis of S. suis disease and may contribute to virulence in 
different serotype and ST strains, and thus should be investigated further in vitro and/or 
in vivo. High resistance to antibiotic classes widely used in the pig industry, but not 
typically used to treat S. suis infections, was predicted (tetracycline and erythromycin 





continuing susceptibility to major treatment drugs in S. suis. One limitation, however, is 
we did not investigate gene mutations conferring antibiotic resistance. Overall, several 
isolates possessed MGEs and horizontal transfer of ARGs (and VAGs) is possible but did 
not appear to play a major role. MGE-linked resistance genes were predominantly present 
in commensal and possibly opportunistic isolates which are frequently exposed to 
therapeutic and nontherapeutic antibiotics. 
In conclusion, this dissertation has contributed to a better understanding of S. suis 
in the United States. We described the distributions and prevalence of pathogenic 
subtypes that may be contributing to the persistence and severity of S. suis infections in 
swine herds. Previously published and novel VAGs proposed through our research may 
serve as targets for diagnostics or for experimental studies testing their roles in virulence 
or as vaccine candidates. Additionally, the WGS-based approach can be utilized for 
characterizing isolates from a particular farm or production system and aid in the 
monitoring and targeting of relevant strains for control and prevention strategies. Finally, 
S. suis disease is complex and multifactorial. The development and standardization of 
animal models for defining S. suis virulence and the international agreement on virulent 
strains are some recommendations that S. suis researchers should keep in mind. This 
could help reduce the variability in results produced by different research groups, 
therefore, improving the study of pathogenesis and virulence and the discovery of 
relevant virulence factors. 
Finally, future research directions include the development of in vitro and/or in 
vivo tests for confirming the virulence of suspected pathogenic strains from the United 
States. As mentioned previously, the presence of virulence-associated factors does not 
guarantee virulence, thus prevalent pathogenic strains, such as serotype 1/2 ST28, should 
be evaluated alongside suspected commensal strains. Proposed VAGs from this 
dissertation may be further tested in a global collection of S. suis isolates including 
agreed-upon virulent and avirulent references. This would provide information on 





of virulence. Characterization of proteins encoded by the novel VAGs (Chapter 4) and 
evaluation of their immunogenic properties may provide evidence on whether the novel 
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Appendix 4.1: Genome assembly and annotation statistics of S. suis isolates (n=208). 
 




















2015UMN3713.8 SRR9123061 2133653 87 41.13 172 2064 47393 15 
2015UMN3791.4 SRR9123062 2169901 61 41.02 171 2093 76636 8 
2014UMN2806.2 SRR9123063 2224364 90 40.95 163 2151 51645 12 
2014UMN3951.1 SRR9123064 2241982 85 41.17 172 2100 59849 11 
2014UMN4255.1 SRR9123065 2416440 223 41.32 177 2399 22465 32 
2015UMN43.3 SRR9123066 2092370 60 41.15 196 2000 80070 10 
2016UMN917.8 SRR9123067 2101247 56 41.14 214 2005 80351 10 
2015UMN3425.7 SRR9123068 2170891 56 41.01 179 2094 81926 8 
2016UMN1470.8 SRR9123069 2184186 62 41.07 203 2151 69317 11 
2016UMN1440.1 SRR9123070 2199101 145 40.97 211 2157 26227 29 
2015UMN3851.7 SRR9123071 2028878 42 41.17 224 1928 92659 7 
2015UMN4009.2 SRR9123072 2019660 96 41.25 209 1914 44021 16 
2015UMN3832.5 SRR9123073 2170615 56 41.01 198 2098 81900 8 
2015UMN3849.1 SRR9123074 2137131 72 41.1 220 2073 63045 12 
2016UMN102.5 SRR9123075 2096333 59 41.15 208 2004 77848 10 
2016UMN125.4 SRR9123076 2028881 47 41.42 223 1865 122409 6 
2017UMN1562.91 SRR9123077 2211674 88 41.18 230 2050 75915 10 
2017KSU2054.24 SRR9123078 2112418 110 41.22 239 2025 39848 14 
2017UMN1574.421 SRR9123079 2040766 102 41.32 266 1955 43796 14 
2017UMN1562.912 SRR9123080 2407512 146 41.29 191 2346 31473 23 
2017UMN1464.2 SRR9123081 2139699 93 41.16 266 2113 38178 17 
2017UMN1464.4 SRR9123082 2147652 87 41.14 296 2125 40175 16 
2017UMN1562.93 SRR9123084 2002592 112 41.55 222 1905 38729 18 
2017UMN1562.911 SRR9123085 2149228 62 41.16 247 1979 113271 6 
2017UMN1562.95 SRR9123086 2405645 166 41.43 165 2346 32764 25 
2014UMN3704.91B SRR9123087 2102433 57 41.16 198 2006 75592 10 
2014UMN3704.91A SRR9123088 2099068 65 41.18 187 2002 57370 11 
2014UMN3631.1 SRR9123089 2203530 52 41.07 217 2145 91778 9 
2014UMN3368.9 SRR9123090 2082904 71 41.15 221 1981 61658 12 





2014UMN4309.1 SRR9123092 2138539 71 41.12 189 2105 63042 13 
2014UMN3038.4 SRR9123093 2305564 55 40.94 194 2311 103353 9 
2014UMN1785.4 SRR9123094 2175372 72 41.05 168 2154 66862 12 
2014UMN3602.9 SRR9123095 2063805 106 41.18 214 2030 33234 18 
2014UMN3212 SRR9123096 2122961 55 41.09 208 2069 67579 10 
2015UMN56.5 SRR9123097 2136532 71 41.06 220 2083 61304 13 
2015UMN1614.1 SRR9123098 2163030 84 41.07 170 2107 66109 12 
2016UMN209.8 SRR9123099 2144840 81 41.09 223 2085 55302 15 
2016UMN146.4 SRR9123100 2119510 75 41.12 227 2075 72976 11 
2016UMN362.1 SRR9123101 2184262 71 41.03 201 2149 68198 10 
2016UMN274.7 SRR9123102 2134295 78 41.14 206 2104 43906 16 
2016UMN578.4 SRR9123103 2241933 69 40.89 260 2181 96464 9 
2016UMN462.4 SRR9123104 1963774 83 41.44 246 1935 51235 13 
2016UMN835.2 SRR9123105 2127607 65 40.93 258 2023 91279 9 
2016UMN668.5 SRR9123106 2023234 31 41.22 194 1926 129396 5 
2016UMN924.3 SRR9123107 2234671 84 40.95 206 2157 64035 11 
2016UMN884.2 SRR9123108 2133522 78 41.14 216 2057 52237 12 
2014KSU2091.1 SRR9123109 2161751 61 41.34 287 2023 67967 10 
2014KSU939.9 SRR9123110 2017386 36 41.25 265 1926 118548 5 
2017KSU2087.212T SRR9123111 2391036 156 41.3 183 2318 29307 25 
2017KSU2054.29R SRR9123112 2373909 145 41.24 223 2259 33917 24 
2017KSU2087.221AT SRR9123113 2198471 44 41.11 241 2205 138187 6 
2017KSU2087.212V SRR9123114 2393612 154 41.3 216 2319 32397 22 
2017KSU1243.9 SRR9123115 2114006 56 41.13 247 2059 80835 9 
2017KSU220.2 SRR9123116 2073537 49 41.34 268 1976 88722 8 
2014KSU27.8 SRR9123117 2128200 75 41.32 220 2029 56403 11 
2017KSU1528.8 SRR9123118 2136328 86 41.19 255 2089 69605 9 
2014UMN3794.6 SRR9123119 2109567 76 41.14 168 2014 64050 12 
2014UMN3978.4 SRR9123120 2120359 66 41.09 226 2073 66661 11 
2015UMN647.4 SRR9123121 2245951 89 40.99 166 2229 50494 10 
2015UMN1735.7 SRR9123122 2401604 90 41.05 192 2321 54798 16 
2015UMN344.2 SRR9123123 2450758 174 41.23 109 2395 25954 32 
2015UMN638.1 SRR9123124 2105077 64 41.14 177 2054 65873 12 
2015UMN64.3 SRR9123125 2411509 158 41.17 160 2335 26490 27 
2015UMN277.7 SRR9123126 2110326 59 41.06 210 2009 100845 6 
2015UMN1499.5 SRR9123127 2141587 77 41.15 181 2117 51723 14 
2014UMN4352.4 SRR9123128 1968827 128 41.48 170 1942 30124 21 





2014UMN3624.71 SRR9123130 2084029 58 41.26 203 2022 72808 11 
2014UMN1700.2 SRR9123131 2226070 84 41.02 164 2216 63051 13 
2014UMN1245 SRR9123132 2183940 102 41.18 164 2124 58697 12 
2016UMN2885.2 SRR9123133 2161901 70 41.04 239 2128 72885 10 
2016UMN2940.9 SRR9123134 2097059 64 41.15 171 2003 82390 10 
2016UMN2677.3 SRR9123135 2112850 52 41.1 233 2070 80590 9 
2016UMN2813.1 SRR9123136 2042805 58 41.25 270 1953 77041 9 
2016UMN2628.1 SRR9123137 2052010 57 41.26 139 1987 95544 8 
2016UMN2642.9 SRR9123138 2166581 66 41.03 243 2134 75341 10 
2017UMN631.2 SRR9123139 2040444 82 41.26 216 1949 52970 13 
2016UMN2627.9 SRR9123140 2052611 57 41.26 257 1986 76697 9 
2017UMN540.4 SRR9123141 2092379 68 41.16 257 1994 61345 13 
2017UMN564.5 SRR9123142 2140566 78 41.17 292 2110 60562 14 
2016UMN1917.1 SRR9123143 2043833 96 41.36 210 2014 45090 13 
2016UMN1250.1 SRR9123144 2113187 117 40.98 188 1999 52820 12 
2015UMN4053.5 SRR9123145 2161052 56 41.03 198 2102 85422 9 
2015UMN4083.1 SRR9123146 2150305 63 41.12 208 2128 67567 12 
2015UMN4145.9 SRR9123147 2088616 59 41.16 226 1992 80351 10 
2016UMN574.9 SRR9123148 2217752 70 40.88 203 2162 75366 11 
2015UMN3479.3 SRR9123149 2056255 40 41.23 212 1994 95594 6 
2015UMN3767.2 SRR9123150 2134669 65 41.13 215 2107 67617 11 
2015UMN3812.4 SRR9123151 2120916 39 41.01 170 2077 77385 7 
2015UMN3886.2 SRR9123152 2106236 60 41.14 184 2057 80555 9 
2016UMN3248.4 SRR9123153 2070581 77 41.21 249 1975 53864 14 
2017UMN1574.428 SRR9123154 2412133 125 41.3 221 2346 41599 18 
2016UMN3117.3 SRR9123155 2119061 26 41.19 260 1984 260919 3 
2016UMN3106.8 SRR9123156 2244112 69 40.97 245 2221 61894 11 
2016UMN3242.3 SRR9123157 2169958 62 41.01 187 2096 80192 9 
2016UMN3120.1 SRR9123158 2060835 39 41.19 256 1995 119634 6 
2016UMN2965.6 SRR9123159 2052180 45 41.25 277 1986 103976 7 
2016UMN2948.1 SRR9123160 2155401 70 41.05 232 2126 71723 11 
2016UMN3047 SRR9123161 2079770 57 41.19 236 2032 66773 12 
2016UMN3027.6 SRR9123162 2109665 68 41.15 288 2064 67542 12 
2014UMN3720.5 SRR9123163 2106351 59 41.1 195 2056 66628 11 
2014UMN3930.3 SRR9123164 2125476 64 41.15 65 2061 101438 8 
2015UMN147.1 SRR9123165 2129931 83 41.17 180 2053 44719 15 
2015UMN865.5 SRR9123166 2141926 59 41.11 184 2113 73707 11 





2014UMN1803 SRR9123168 2137122 116 41.2 163 2105 29774 21 
2014UMN2149 SRR9123169 2101431 39 41.26 180 2054 119532 7 
2014UMN3295.5 SRR9123170 2072110 75 41.2 203 2029 63137 12 
2016UMN763.3 SRR9123171 2228371 113 40.89 175 2153 76292 10 
2016UMN858.4 SRR9123172 2056642 39 41.23 150 1997 103996 6 
2016UMN2500.62B SRR9123173 2074220 123 41.17 236 1992 33187 23 
2017UMN355.91 SRR9123174 2110762 81 41.14 283 1997 57687 13 
2016UMN1245.7 SRR9123175 2150269 73 41.12 206 2125 63189 13 
2016UMN1367.1 SRR9123176 2047385 66 41.26 220 1961 74102 11 
2016UMN1452.1 SRR9123177 2071333 34 41.37 187 1924 142166 6 
2015UMN3869.3 SRR9123178 2239872 80 40.93 230 2165 76261 10 
2016UMN2465.63A SRR9123179 2301650 49 40.84 191 2308 123888 8 
2016UMN2465.63B SRR9123180 2053443 56 41.07 240 2010 63088 10 
2016UMN2500.63 SRR9123181 2076066 43 41.05 192 1978 129611 6 
2016UMN2500.62A SRR9123182 2073378 120 41.17 217 1990 33858 23 
2015UMN2869.3 SRR9123183 2171471 57 41.02 179 2096 66771 9 
2015UMN2795.3 SRR9123184 2124792 70 41.03 170 2009 64658 10 
2015UMN1613.2 SRR9123185 2152201 72 41.14 141 2131 61852 13 
2015UMN1502.7 SRR9123186 2120054 73 41.12 149 2082 63251 12 
2015UMN1933.2 SRR9123187 2141803 71 41.15 143 2114 50682 14 
2015UMN1635.9 SRR9123188 2163934 59 41.22 158 2142 75521 10 
2015UMN2430.5 SRR9123189 1952168 55 41.35 156 1854 73970 9 
2015UMN2400.6 SRR9123190 1972371 31 41.4 197 1897 120217 5 
2015UMN2626.7 SRR9123191 2183732 55 41.01 163 2115 74913 11 
2015UMN2473.3 SRR9123192 2079133 91 41.16 163 1980 50741 14 
2014UMN3749.9 SRR9123193 2109815 75 41.12 145 2014 75384 10 
2014UMN3627 SRR9123194 2142769 73 41.14 181 2113 63120 13 
2014UMN3243.9 SRR9123195 2145257 125 41.34 104 2071 30843 20 
2014UMN2470.9 SRR9123196 2312752 123 41.44 177 2186 38099 21 
2015UMN1919.5 SRR9123197 2229125 99 40.96 175 2169 66126 10 
2015UMN745.2 SRR9123198 2328621 135 41.51 147 2215 38112 22 
2015UMN370.7 SRR9123199 2164307 79 41.07 208 2108 66628 11 
2015UMN370.6 SRR9123200 2397694 94 41.56 170 2272 54304 14 
2015UMN367.3 SRR9123201 2138103 74 41.11 215 2083 55200 13 
2015UMN302.5 SRR9123202 2111029 66 41.16 208 2084 71722 10 
2017UMN236.4 SRR9123203 2260763 67 41.01 228 2260 104107 7 
2017UMN74.9 SRR9123204 2140173 77 41.17 249 2112 60562 14 





2016UMN1524.93 SRR9123206 2005990 53 41.37 318 1943 71696 8 
2017UMN1435.22 SRR9123207 2107190 29 41.47 277 1971 205235 4 
2017UMN1435.21 SRR9123208 2146410 102 41.2 224 2077 49940 15 
2017UMN937.8 SRR9123209 2149814 73 41.14 302 2003 58327 11 
2017UMN355.92 SRR9123210 2076642 15 41.3 272 1946 327963 3 
2016KSU16.8 SRR9123211 2154414 81 41.13 283 2106 57371 13 
2015KSU2327.2 SRR9123212 2163061 57 41.35 270 2030 74081 9 
2016KSU697.6 SRR9123213 2095507 80 41.17 197 2045 54734 12 
2016KSU47.5 SRR9123214 2208929 51 40.91 261 2172 152118 6 
2017UMN1562.92B SRR9123215 2398283 178 41.45 161 2336 28907 27 
2017UMN524.8 SRR9123217 2117117 65 41.14 248 2076 62416 11 
2017UMN416.5 SRR9123218 2137640 86 41.17 266 2110 51032 13 
2015UMN1018.1 SRR9123219 2210117 71 41.04 164 2171 55281 12 
2015UMN1502.6 SRR9123220 2122679 62 41.09 143 2088 67679 13 
2015UMN592.5 SRR9123221 2146547 59 41.1 197 2118 80407 9 
2015UMN637.3 SRR9123222 2152044 79 41.12 199 2106 50650 14 
2015UMN122.1 SRR9123223 2088904 62 41.14 213 1996 77852 11 
2015UMN138 SRR9123224 2084808 67 41.16 174 1983 61986 12 
2015UMN856 SRR9123225 2141782 66 41.14 199 2114 63189 13 
2015UMN890.4 SRR9123226 2165776 73 41.01 158 2106 63042 11 
2015UMN689 SRR9123227 2073216 82 41.2 167 2029 47033 14 
2015UMN720.1 SRR9123228 2181035 48 41.03 188 2118 100845 7 
2015UMN193.2 SRR9123229 2177436 111 40.98 177 2092 50374 12 
2015UMN193.3 SRR9123230 2170533 41 41.02 185 2126 127296 6 
2015UMN3222.1 SRR9123231 2196422 82 40.94 197 2097 64580 11 
2015UMN3436.5 SRR9123232 2174324 84 41.06 159 2149 51682 14 
2014UMN2228.9 SRR9123233 2041137 61 41.29 170 1950 70847 10 
2014UMN2148.7 SRR9123234 2112649 95 41.04 188 2064 32748 20 
2014UMN2784.1 SRR9123235 1963631 78 41.44 68 1937 51236 12 
2014UMN2436.2 SRR9123236 2150682 71 41.12 163 2127 63189 13 
2014UMN3624.74 SRR9123237 2121635 57 41.05 225 2079 70605 9 
2014UMN3342.6 SRR9123238 2120569 79 41.22 204 2099 55166 14 
2017UMN92.8 SRR9123239 2304127 81 40.76 269 2246 60139 16 
2017UMN144.4 SRR9123240 2039646 87 41.3 214 1948 58785 12 
2017UMN145.1 SRR9123241 2110421 58 41.11 324 2011 97569 8 
2017UMN164.7 SRR9123242 2109280 53 41.29 244 1975 84844 9 
2016UMN3250.3 SRR9123243 2091935 61 41.14 220 1998 74643 9 





2017UMN55.9 SRR9123245 2084953 55 41.26 269 2022 87201 9 
2017UMN92.6 SRR9123246 2135788 66 41.13 266 2104 63201 12 
2017UMN196 SRR9123247 2104094 57 41.12 268 2051 72225 10 
2017UMN266.4 SRR9123248 2290451 52 40.9 226 2290 84606 7 
2014UMN3928.6 SRR9123249 2089700 56 41.13 197 1994 80466 9 
2014UMN3787.2 SRR9123250 2095657 80 41.18 191 2039 47343 15 
2014UMN3786.4 SRR9123251 2215337 128 41.13 202 2153 33175 18 
2014UMN3714.6 SRR9123252 2133238 65 41.04 170 2089 65685 11 
2015UMN27.5 SRR9123253 2119784 84 41.16 194 2039 50775 15 
2014UMN4118.6 SRR9123254 2060292 80 41.21 236 2016 47541 12 
2014UMN4033.5 SRR9123255 2153974 67 41.14 215 2134 62611 12 
2014UMN4007.5 SRR9123256 2104869 66 41.14 183 2054 75309 10 
2015UMN80.9 SRR9123257 2029198 34 41.17 207 1927 129563 6 
2015UMN36 SRR9123258 2051596 56 41.27 205 1988 81784 8 
2017UMN583.4 SRR9123259 2207148 71 41.18 255 2140 81650 10 
2017UMN539.9 SRR9123260 2166887 112 41.11 215 2130 48052 14 
2017UMN500.8 SRR9123261 2082771 78 41.16 239 1978 55190 14 
2017UMN296.1 SRR9123262 2114516 71 41.05 287 2014 63719 12 
2017UMN1049.2 SRR9123263 2045217 80 41.23 235 1953 61006 12 
2017UMN1049.1 SRR9123264 2179209 111 40.99 253 2073 58398 12 
2017UMN991.6 SRR9123265 2163161 60 41 182 2093 85422 8 
2017UMN834.1 SRR9123266 2108145 73 41.19 261 2079 53081 12 
2017UMN1417.8 SRR9123267 2108632 118 41.18 207 2048 36369 19 
2017UMN1161.8 SRR9123268 2241865 142 41.08 240 2198 41104 17 
 
 
 
